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Parkinson’s	  Disease	  (PD)	  is	  a	  degenerative	  neurological	  disease	  affecting	  
aspects	  of	  movement,	  including	  speech.	  	  Persons	  with	  PD	  are	  reported	  to	  have	  
better	  speech	  functioning	  in	  the	  clinical	  setting	  than	  in	  the	  home	  setting,	  but	  this	  has	  
not	  been	  quantified.	  New	  methodologies	  in	  ambulatory	  measures	  of	  speech	  are	  
emerging	  that	  allow	  investigation	  of	  non-­‐clinical	  settings.	  
The	  following	  questions	  are	  addressed:	  Is	  speech	  different	  between	  
environments	  in	  PD	  and	  in	  healthy	  controls?	  	  Can	  clinical	  tasks	  predict	  speech	  
behaviors	  in	  the	  home?	  	  Is	  treatment	  proven	  effective	  by	  measures	  in	  the	  home?	  
What	  can	  we	  glean	  from	  methods	  of	  measurement	  of	  speech	  function	  in	  the	  home?	  	  	  
The	  experiment	  included	  13	  persons	  with	  PD	  and	  12	  healthy	  controls,	  
studied	  in	  the	  clinical	  and	  home	  environments,	  and	  7	  of	  those	  13	  persons	  with	  PD	  
participated	  in	  a	  treatment	  study.	  	  	  
Major	  findings	  included:	  Spontaneous	  speech	  intelligibility,	  not	  intensity,	  was	  
the	  differentiating	  factor	  between	  persons	  with	  PD	  and	  healthy	  controls.	  	  
Intelligibility	  and	  intensity	  were	  not	  related.	  	  Both	  groups	  presented	  with	  higher	  
sentence	  intensity	  in	  the	  home	  environment.	  Spontaneous	  speech	  intelligibility	  in	  
the	  clinic	  was	  related	  to	  spontaneous	  speech	  intelligibility	  in	  the	  home.	  The	  
Sentence	  Intelligibility	  Test	  emerged	  as	  the	  best	  predictor	  of	  spontaneous	  speech	  
intelligibility	  in	  the	  home.	  	  Differences	  between	  pilot	  treatment	  groups	  measured	  in	  
the	  home	  on	  intensity	  and	  intelligibility	  were	  not	  large	  enough	  to	  make	  a	  clinical	  
trial	  feasible.	  	  Individual	  differences	  may	  account	  for	  many	  of	  these	  results,	  for	  




Drawing	  conclusions	  regarding	  the	  home	  environment	  via	  measures	  outside	  
the	  home	  should	  be	  carefully	  considered.	  	  Ambulatory	  measures	  of	  speech	  are	  a	  
viable	  option	  for	  studying	  speech	  function	  in	  non-­‐clinical	  settings,	  and	  technology	  is	  
advancing.	  	  Further	  investigation	  is	  needed	  to	  develop	  methodologies	  and	  
normative	  values	  for	  speech	  in	  the	  home.	  	  




Parkinson’s	  disease	  (PD)	  is	  a	  neurological	  disorder	  that	  involves	  the	  loss	  of	  
dopamine	  producing	  cells	  in	  the	  basal	  ganglia,	  with	  disease	  progression	  to	  affect	  the	  
cortex	  	  (Braak	  et	  al.,	  2003;	  Del	  Tredici,	  Rub,	  de	  Vos,	  Bohl,	  &	  Braak,	  2002).	  	  In	  2005,	  
between	  4.1	  and	  4.6	  million	  people	  worldwide	  over	  the	  age	  of	  50	  were	  estimated	  to	  
have	  PD.	  This	  number	  was	  projected	  to	  more	  than	  double	  to	  between	  8.7	  and	  9.3	  
million	  by	  the	  year	  2030	  	  (Dorsey	  et	  al.,	  2007).	  	  Symptoms	  of	  PD	  include	  resting	  
tremor,	  reduced	  range	  of	  movement	  (rigidity)	  and	  slow	  movement	  (bradykinesia)	  
all	  of	  which	  affect	  functions	  such	  as	  walking,	  speech	  and	  writing	  (Gelb,	  Oliver,	  &	  
Gilman,	  1999).	  	  As	  these	  symptoms	  progress,	  the	  affected	  person	  may	  have	  difficulty	  
walking,	  talking,	  or	  completing	  simple	  tasks.	  	  Studies	  of	  limb	  movement	  show	  that	  
persons	  with	  PD	  have	  motor	  execution	  difficulties	  due	  to	  rigidity	  and	  bradykinesia	  
(DeLong	  &	  Georgopoulos,	  2011;	  Morris,	  Iansek,	  Matyas,	  &	  Summers,	  1994;	  Stelmach,	  
Teasdale,	  Phillips,	  &	  Worringham,	  1989).	  All	  of	  the	  speech	  subsystems	  (respiratory,	  
laryngeal,	  and	  supralaryngeal)	  can	  be	  affected	  in	  persons	  with	  PD	  (Connor,	  Abbs,	  
Cole,	  &	  Gracco,	  1989;	  Duffy,	  2012;	  Forrest,	  Weismer,	  &	  Turner,	  1989;	  Hammer	  &	  
Barlow,	  2010;	  Huber	  &	  Darling,	  2011;	  Sadagopan	  &	  Huber,	  2007).	  	  Environmental	  
cues	  have	  been	  shown	  to	  improve	  motor	  movements	  in	  PD	  (Ho,	  Bradshaw,	  Iansek,	  &	  
Alfredson,	  1999;	  Oliveira,	  Gurd,	  Nixion,	  Marshall,	  &	  Passingham,	  1997)	  
Eighty-­‐nine	  percent	  of	  those	  with	  PD	  have	  voice	  problems	  and	  45%	  have	  
articulation	  problems	  (Logemann,	  Fisher,	  Boshes,	  &	  Blonsky,	  1978).	  Persons	  with	  
PD	  patients	  suffer	  from	  hypokinetic	  dysarthria,	  which	  includes	  reduced	  voice	  
loudness,	  monoloudness,	  monopitch,	  disordered	  rate,	  disordered	  articulation,	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hoarse,	  breathy,	  or	  harsh	  voice	  and/or	  tremulous	  voice	  	  (Darley,	  Aronson,	  &	  Brown,	  
1969b;	  Logemann	  et	  al.,	  1978).	  	  
Several	  objective	  and	  subjective	  measures	  of	  hypophonia	  and	  dysarthria	  are	  
included	  in	  a	  standard	  speech	  and	  voice	  evaluation	  for	  PD	  and	  related	  disorders	  	  
(Hillman,	  Montgomery,	  &	  Zeitels,	  1997;	  Roy	  et	  al.,	  2013).	  	  The	  preferred	  practice	  
patterns	  for	  Speech–Language	  Pathologists	  	  (American	  Speech-­‐Language-­‐Hearing	  
Association,	  2004)	  for	  voice	  and	  motor	  speech	  assessments	  include	  the	  
measurement	  of:	  mean	  sound	  pressure	  level	  (SPL)	  in	  a	  prolonged	  vowel,	  range	  of	  
SPL	  (SPL-­‐Δ),	  the	  Consensus	  Auditory	  Perceptual	  Evaluation	  of	  Voice	  (CAPE-­‐V)	  	  
(Kempster,	  Gerratt,	  Abbott,	  Barkmeier-­‐Kraemer,	  &	  Hillman,	  2009;	  Zraick	  et	  al.,	  
2011),	  Sentence	  Intelligibility	  Test	  (SIT)	  (Yorkston,	  Beukelman,	  &	  Tice,	  1996),	  
maximum	  phonation	  time	  (MPT),	  harmonic	  to	  noise	  ratio	  (HNR),	  fundamental	  
frequency	  (F0),	  and	  range	  of	  F0	  (F0-­‐Δ).	  	  Clinicians	  will	  also	  often	  include	  quality	  of	  
life	  scales	  such	  as	  the	  Voice	  Handicap	  Index	  (VHI)	  (Jacobson	  et	  al.,	  1997).	  Speech	  
disorders	  that	  accompany	  PD	  impair	  intelligibility	  	  (Duffy,	  2012).	  Estimates	  of	  
speech	  intelligibility	  are	  often	  used	  to	  determine	  if	  a	  neurological	  disease	  affects	  the	  
speech	  mechanism	  and	  to	  index	  the	  severity	  of	  the	  impairment	  in	  everyday	  life	  	  (R.	  
Kent	  et	  al.,	  1989).	  
Treatment	  approaches	  for	  dysarthria	  in	  PD	  (i.e.	  rate	  reduction,	  increased	  
voice	  loudness,	  and	  “clear	  speech”	  usually	  involving	  increased	  effort	  and/or	  
overarticulation)	  extend	  across	  an	  entire	  utterance	  and	  impact	  multiple	  speech	  
components	  (i.e.	  respiration,	  phonation,	  articulation,	  resonance)	  (Yorkston,	  Hakel,	  
Beukelman,	  &	  Fager,	  2007).	  These	  treatment	  techniques	  are	  intended	  to	  improve	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speech	  intelligibility	  	  (Duffy,	  2012;	  Fox,	  Morrison,	  Ramig,	  &	  Sapir,	  2002;	  Weismer,	  
Yunusova,	  &	  Bunton,	  2012;	  Yorkston	  et	  al.,	  2007)	  by	  improving	  multiple	  speech	  
components,	  including	  phonation.	  Therapy	  techniques	  that	  instruct	  patients	  to	  use	  
“loud”	  and	  “clear”	  speech	  show	  improvement	  in	  intelligibility	  in	  the	  clinical	  setting	  
(Ramig,	  1992;	  K.	  Tjaden,	  Sussman,	  &	  Wilding,	  2014).	  The	  Lee	  Silverman	  Voice	  
Therapy	  LOUD	  program	  (LSVT-­‐LOUD)	  uses	  the	  sole	  instruction	  of	  “think	  loud,”	  to	  
focus	  on	  voice	  loudness,	  which	  impacts	  multiple	  speech	  components	  simultaneously	  
and	  increase	  speech	  intelligibility	  	  (Fox	  et	  al.,	  2002;	  Ramig,	  1992).	  
Treatment	  approaches	  that	  include	  environmental	  cues,	  such	  as	  the	  wearable	  
SpeechVive	  device,	  are	  also	  being	  developed.	  	  Instead	  of	  telling	  the	  patient	  explicitly	  
to	  increase	  the	  their	  speech	  loudness,	  the	  SpeechVive	  delivers	  cocktail	  chatter	  to	  the	  
patient	  through	  one	  ear	  and	  employs	  the	  Lombard	  effect	  so	  that	  the	  patient	  will	  
speak	  more	  loudly	  in	  the	  presence	  of	  the	  background	  noise	  (Pick	  &	  al.,	  1989;	  
Stathopoulos	  et	  al.,	  2014).	  	  Principles	  of	  practice	  and	  exercise	  physiology	  indicate	  
that	  heavier	  loading	  on	  the	  muscles	  results	  in	  increased	  strength	  	  (Taaffe,	  Duret,	  
Wheeler,	  &	  Marcus,	  1999).	  	  Currently	  Huber	  and	  colleagues	  are	  evaluating	  whether	  
12	  weeks	  use	  of	  the	  Speech	  Vive	  increases	  speech	  intensity	  and	  intelligibility	  	  
(Stathopoulos	  et	  al.,	  2014).	  The	  study	  measured	  patients’	  intensity	  and	  intelligibility	  
in	  their	  natural	  environment,	  pre-­‐	  and	  post-­‐	  12	  weeks	  of	  SpeechVive™	  treatment.	  	  
Patients’	  speech	  intelligibility	  and	  intensity	  were	  measured	  when	  not	  wearing	  the	  
device.	  
Improved	  intelligibility	  is	  the	  primary	  aim	  of	  treatment;	  however,	  this	  has	  
not	  been	  measured	  as	  a	  result	  of	  speech	  therapies	  for	  PD	  	  (Deane	  et	  al.,	  2002).	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Intelligibility	  is	  defined	  as	  “the	  degree	  to	  which	  the	  speaker’s	  intended	  message	  is	  
recovered	  by	  the	  listener,”	  	  (R.	  Kent	  et	  al.,	  1989).	  When	  judging	  intelligibility	  within	  
the	  clinical	  context	  (speech	  therapy	  office,	  rehab	  setting,	  laboratory),	  Hawthorne,	  
behavioral	  and	  task	  effects	  should	  be	  considered	  	  (Franke	  &	  Kaul,	  1978;	  McCarney	  
et	  al.,	  2007a;	  Wickström	  &	  Bendix,	  2000).	  	  Reading	  tasks	  such	  as	  the	  SIT,	  allow	  
patients	  to	  concentrate	  on	  how	  they	  are	  speaking,	  while	  in	  natural	  communication	  
settings	  patients	  must	  formulate	  what	  they	  are	  going	  to	  say	  in	  addition	  to	  how	  they	  
are	  speaking	  	  (Connor	  &	  Abbs,	  1991;	  Kempler	  &	  Lancker,	  2002;	  Yorkston,	  2010).	  	  	  	  
Even	  in	  controlled	  environments,	  the	  effect	  of	  task	  can	  be	  seen.	  	  In	  a	  single	  
case	  study	  involving	  a	  male	  with	  PD,	  5	  tasks	  in	  the	  clinic	  were	  transcribed	  for	  a	  
percentage	  of	  intelligibility	  (spontaneous	  speech,	  repetition,	  reading,	  repeated	  
singing,	  spontaneous	  singing),	  and	  intelligibility	  in	  spontaneous	  speech	  (29%)	  was	  
significantly	  lower	  than	  in	  the	  other	  four	  tasks	  (78-­‐88%)	  	  (Kempler	  &	  Lancker,	  
2002).	  
The	  primary	  interest	  of	  this	  work	  is	  a	  comparison	  of	  two	  distinctly	  defined	  
environments.	  	  For	  the	  purposes	  of	  this	  project,	  consider	  “in	  the	  clinic,”	  to	  mean	  any	  
controlled	  clinical	  or	  lab	  environment.	  	  These	  may	  include	  outpatient	  treatment	  
rooms,	  inpatient	  hospital	  beds,	  university	  laboratories,	  etc.	  	  Structured	  speech	  tasks	  
are	  elicited	  in	  the	  clinic	  environment,	  and	  spontaneous	  speech	  may	  take	  place	  as	  
well.	  	  The	  “natural	  environment,”	  refers	  to	  those	  places	  in	  which	  the	  participants	  
would	  normally	  find	  themselves.	  	  These	  may	  include	  home,	  church,	  a	  friend	  or	  
family	  member’s	  house,	  the	  market,	  the	  workplace,	  etc.	  	  	  Structured	  speech	  tasks	  are	  
not	  elicited	  in	  the	  natural	  environment;	  spontaneous	  conversational	  speech	  is	  the	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item	  of	  interest	  here.	  	  More	  specifically,	  the	  “home	  environment”	  includes	  that	  
environment	  where	  the	  participants	  were	  communicating	  with	  their	  primary	  
communication	  partner(s)	  in	  their	  most	  familiar	  environment,	  and	  in	  reference	  to	  
this	  project,	  “clinical	  environment,”	  is	  the	  described	  laboratory	  where	  testing	  took	  
place.	  
Differences	  in	  speech	  produced	  in	  the	  clinic	  versus	  in	  the	  natural	  
environment	  in	  spontaneous	  situations	  have	  been	  reported	  anecdotally	  and	  in	  the	  
literature	  for	  speakers	  with	  PD	  	  (Keintz,	  Bunton,	  &	  Hoit,	  2007;	  Sarno,	  1968;	  
Weismer,	  1984).	  	  Patients	  tend	  to	  focus	  on	  a	  single	  task,	  speech	  production,	  when	  
performing	  nearly	  any	  evaluative	  task	  in	  the	  clinical	  environment.	  	  However,	  in	  the	  
natural	  environment	  attention	  is	  divided	  from	  speech	  production	  in	  order	  to	  
coordinate	  the	  demands	  of	  speech	  production	  with	  those	  of	  functional	  
communication	  and	  other	  activities,	  causing	  many	  stimuli	  to	  compete	  for	  resources	  	  
(Dromey	  &	  Benson,	  2003).	  	  Keitz	  et	  al.	  (2007)	  observed	  in	  their	  pilot	  speakers	  with	  
PD	  a	  substantial	  performance	  effect	  (judged	  by	  authors	  and	  spouses	  of	  participants)	  
where	  patients	  would	  be	  much	  more	  intelligible	  during	  clinical	  tasks	  than	  was	  
typical	  during	  natural	  environment	  conversation.	  	  This	  is	  consistent	  with	  findings	  by	  
Sarno	  (1968)	  and	  Weismer	  (1984).	  	  Sarno	  delineated	  between	  “clinical	  performance”	  
and	  “functional	  performance,”	  much	  in	  the	  same	  ways	  as	  this	  project	  delineates	  
between	  the	  clinical	  and	  natural	  environments.	  	  She	  found	  it	  “unfortunate”	  that	  the	  
standard	  of	  practice	  was	  to	  exclusively	  measure	  speech	  impairments	  using	  clinical	  
performance,	  as	  there	  was	  such	  a	  disparity	  between	  clinical	  and	  functional	  speech	  
performance,	  “especially	  true	  in	  patients	  who	  have	  Parkinson’s	  disease.”	  	  Years	  later,	  
RUNNING	  HEAD:	  SPEECH	  FUNCTION	  IN	  PD;	  ENVIRONMENT,	  TASK,	  TREATMENT	  
	  
6	  
Weismer	  (1984)	  noted	  the	  same	  in	  a	  study	  he	  conducted	  with	  patients	  with	  PD,	  that	  
when	  reviewing	  the	  intelligibility	  of	  those	  with	  PD	  in	  the	  clinical	  setting	  versus	  
“spontaneous”	  situations,	  the	  majority	  of	  the	  subjects	  were	  much	  more	  intelligible	  
when	  producing	  experimental	  sentences	  than	  they	  were	  when	  engaged	  in	  
spontaneous	  speech.	  	  Keitz	  et	  al	  (2007)	  attempted	  to	  synthesize	  more	  naturalistic	  
speech	  in	  their	  full	  study	  by	  introducing	  a	  dual	  task,	  in	  this	  case,	  subjects	  were	  asked	  
to	  read	  sentences	  while	  screwing	  in	  a	  bolt	  with	  their	  non-­‐dominant	  hand.	  	  Ho	  et	  al.	  
(2002)	  also	  used	  this	  strategy,	  as	  well	  as	  Dromey	  and	  Benson	  (2003)	  with	  healthy	  
participants.	  	  	  
In	  this	  project,	  we	  seek	  to	  study	  actual	  spontaneous	  speech	  within	  the	  
natural	  environment,	  appreciating	  these	  researchers’	  efforts	  to	  synthesize	  
naturalistic	  speech	  with	  dual	  tasks.	  	  Motivation,	  environment	  and	  speech	  materials	  
are	  influences	  on	  speech	  production	  and	  resulting	  intelligibility	  	  (Hustad	  &	  Weismer,	  
2007),	  which	  encompass	  the	  majority	  of	  the	  clinical	  evaluation.	  Discreetly	  
measuring	  intelligibility	  and	  intensity	  within	  the	  natural	  environment	  may	  reduce	  
Hawthorne,	  behavioral	  and	  task	  effects	  on	  outcomes.	  	  Questions	  remain	  as	  to	  the	  
relationship	  between	  measurements	  in	  highly	  controlled	  conditions	  and	  more	  
realistic	  conditions	  	  (R.	  D.	  Kent,	  Weismer,	  Kent,	  &	  Rosenbek,	  1989).	  	  To	  assess	  
intelligibility	  in	  the	  natural	  environment	  and	  quantify	  potential	  therapeutic	  effects,	  
measures	  should	  be	  made	  in	  the	  natural	  environment	  or	  in	  a	  clinical	  simulation	  of	  a	  
natural	  communication	  environment.	  This	  project	  seeks	  to	  overcome	  these	  clinical	  
influences	  and	  remaining	  questions	  by	  studying	  the	  natural	  environment	  itself.	  	  	  	  
	   	  




A	  series	  of	  research	  questions	  are	  outlined	  on	  measurement	  of	  speech	  
function	  of	  persons	  with	  PD	  and	  healthy	  controls	  within	  the	  natural	  environment,	  
with	  the	  natural	  environment	  being	  their	  functional	  everyday	  environment	  (home,	  
work,	  church,	  etc.).	  	  Hypophonia	  accompanying	  PD	  is	  characterized	  by	  a	  soft	  voice	  
and	  reduced	  intelligibility	  (Darley,	  Aronson,	  &	  Brown,	  1969a;	  Darley	  et	  al.,	  1969b).	  
Hawthorne	  effects,	  when	  the	  patient	  is	  aware	  that	  their	  speech	  is	  being	  measured,	  
may	  contribute	  to	  differences	  between	  clinical	  and	  environmental	  results	  	  (Deane	  et	  
al.,	  2002).	  	  Communication	  partners	  of	  persons	  with	  PD	  complain	  that	  the	  patient’s	  
voice	  is	  soft	  and	  difficult	  to	  understand.	  These	  complaints	  may	  not	  match	  the	  
patient’s	  speech	  performance	  in	  a	  controlled	  clinical	  environment	  when	  the	  patient	  
is	  focused	  on	  their	  speech	  performance.	  	  In	  controlled	  clinical	  environments,	  
patients	  show	  the	  ability	  to	  adjust	  the	  intensity	  of	  their	  speech	  in	  clinical	  tasks	  and	  
in	  conversation,	  yet	  overestimate	  the	  loudness	  of	  that	  speech	  compared	  with	  
controls	  (Ho,	  Bradshaw,	  &	  Iansek,	  2000;	  Miller	  et	  al.,	  2007).	  	  Questions	  have	  been	  
raised	  in	  the	  literature	  as	  how	  clinical	  speech	  tasks	  generalize	  to	  the	  home	  
environment	  (Keintz	  et	  al.,	  2007;	  Sarno,	  1968;	  Weismer,	  1984).	  	  Efficient	  and	  
effective	  means	  of	  measuring	  speech	  in	  the	  home	  for	  baselines	  and	  treatment	  effects	  
should	  be	  explored.	  	  The	  questions	  presented	  are:	  (1)	  What	  is	  the	  effect	  of	  
environment	  on	  speech	  intensity	  and	  intelligibility?	  (2)	  What	  clinical	  tasks	  might	  
predict	  intelligibility	  and	  intensity	  in	  the	  natural	  environment?	  (3)	  Are	  there	  
treatment	  effects	  on	  spontaneous	  speech	  intelligibility	  and	  intensity	  within	  the	  
home	  environment?	  And	  (4)	  What	  can	  we	  glean	  from	  our	  experience	  of	  measuring	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speech	  in	  the	  home	  environment?	  	  These	  questions	  are	  answered	  and	  new	  
methodologies	  for	  remote	  sensing	  and	  ambulatory	  measures	  of	  speech	  and	  voice	  
are	  introduced	  in	  this	  project.	  
	   	  




This	  project	  is	  a	  first	  step	  in	  developing	  measures	  that	  could	  be	  used	  for	  
evaluation	  of	  patients’	  speech	  functioning	  in	  their	  own	  natural	  environments.	  	  
Research	  is	  needed	  to	  investigate	  whether	  or	  not	  there	  are	  discrepancies	  between	  
clinical	  tasks	  and	  functional	  intelligibility	  in	  the	  natural	  environment,	  and	  the	  effect	  
of	  treatment	  on	  functional	  intelligibility.	  	  Outcomes	  of	  this	  research	  may	  allow	  
practitioners	  to	  gather	  data	  in	  the	  natural	  environment,	  for	  therapy	  planning	  and	  
assessment	  purposes.	  As	  health	  care	  becomes	  more	  patient	  centered,	  the	  focus	  on	  a	  
person’s	  communication	  in	  their	  natural	  environment	  will	  be	  critical,	  and	  accurate	  
assessment	  is	  needed.	  	  The	  World	  Health	  Organization	  states	  that	  health	  must	  
include	  physical,	  mental	  and	  social	  state	  of	  being	  as	  well	  as	  environmental	  factors,	  
melding	  into	  a	  multidimensional	  concept	  	  (World	  Health	  Organization,	  2002).	  	  The	  
aim	  of	  future	  research	  will	  be	  to	  explore	  new	  methods	  for	  the	  development	  of	  
measures	  of	  speech	  and	  voice	  function	  in	  a	  patient’s	  natural	  environment.	  	  
Objective	  measures	  of	  speech	  function	  in	  the	  natural	  environment	  remain	  
illusive	  to	  speech-­‐language	  pathologists.	  	  Natural	  environment	  measures	  of	  speech	  
function	  may	  not	  correlate	  with	  clinical	  measures	  currently	  used	  for	  assessing	  
speech	  or	  voice	  (Deane	  et	  al.,	  2002;	  Hunter,	  2009;	  McAllister	  &	  Brandt,	  2012).	  	  In	  
patients	  with	  hypophonia,	  reports	  of	  quality	  of	  life	  are	  poorly	  related	  to	  acoustic	  
measures	  (Wheeler	  et	  al.,	  2006).	  	  Perceptual	  ratings	  of	  speech	  by	  clinicians	  have	  
poor	  inter-­‐rater	  reliability	  and	  may	  not	  relate	  to	  objective	  acoustic	  measures	  of	  
voice	  (Zraick	  et	  al.,	  2011).	  	  Therapeutic	  approaches	  for	  treatment	  of	  PD	  symptoms	  of	  
hypophonia	  and	  dysarthria	  that	  could	  improve	  intelligibility	  have	  not	  been	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measured	  in	  the	  natural	  environment	  for	  most	  well-­‐known	  therapies	  (Deane	  et	  al.,	  
2002).	  
	   	  




LENA	  is	  a	  small	  wallet	  sized	  portable	  device	  that	  is	  encrypted	  and	  can	  store	  
up	  to	  16	  hours	  of	  acoustic	  recordings.	  	  This	  device	  is	  referred	  to	  as	  a	  Digital	  
Language	  Processor,	  or	  DLP.	  	  When	  worn	  by	  a	  patient,	  the	  DLP	  recordings	  include	  
sound	  in	  the	  patient’s	  environment	  and	  their	  speech,	  recorded	  in	  .wav	  format.	  	  
Originally	  designed	  for	  recording	  environments	  of	  infants,	  software	  provides	  
analysis	  of	  the	  language	  environment	  and	  measures	  of	  language	  development	  data	  
such	  as	  mean	  length	  of	  utterance	  for	  children	  ages	  2	  to	  48	  months	  	  (Gilkerson	  &	  
Richards,	  2009).	  However,	  the	  recorded	  .wav	  file	  is	  easily	  extractable	  from	  the	  
device	  for	  other	  types	  of	  voice	  and	  speech	  analysis.	  	  Praat	  speech	  acoustic	  software	  
allows	  for	  accurate	  analysis	  of	  speech	  acoustics	  	  (Boersma	  &	  Weenink,	  2010).	  	  
As	  .wav	  files	  are	  the	  standard	  for	  acoustic	  analysis,	  these	  files	  can	  be	  played	  for	  
listeners	  when	  transcribing	  speech	  content.	  	  	  
Ziaei,	  Sangwan	  and	  Hansen	  (2012)	  utilized	  LENA	  to	  monitor	  and	  model	  the	  
natural/functional	  audio	  environment	  using	  healthy	  adults	  as	  their	  subjects.	  	  The	  
researchers	  collected	  more	  than	  35	  recordings,	  each	  recording	  lasting	  10	  or	  more	  
hours.	  	  This	  collection,	  which	  is	  known	  as	  the	  “Prof-­‐Life-­‐Log	  corpus,”	  is	  yielding	  a	  
unique	  and	  unprecedented	  opportunity	  to	  explore	  real-­‐world	  natural	  audio	  samples.	  	  
Ziaei	  et	  al.	  gathered	  two	  datasets	  from	  the	  corpus,	  (1)	  a	  controlled	  collection	  with	  
homogenous	  recordings	  of	  various	  environments,	  and	  (2)	  a	  real-­‐world	  naturalistic	  
collection.	  	  Although	  this	  study	  was	  focused	  on	  modeling	  
environmental/background	  noise,	  such	  an	  approach	  could	  be	  used	  to	  monitor	  
spontaneous	  speech	  of	  patients	  with	  PD	  and	  healthy	  controls.	  Such	  measures	  could	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then	  be	  related	  to	  patients’	  voice	  and	  speech	  measures	  in	  a	  clinical	  setting,	  and	  to	  
develop	  pre-­‐	  post-­‐	  treatment	  measures.	  	  These	  will	  be	  the	  first	  steps	  to	  building	  an	  
outcomes	  measurement	  system	  in	  the	  natural	  environment.	  	  
	  
	   	  




To	  determine	  the	  effect	  of	  the	  environment	  on	  speech	  intensity	  and	  
intelligibility	  in	  persons	  with	  PD	  and	  healthy	  controls.	  
Problem.	  	  Hypophonia	  accompanying	  PD	  is	  characterized	  by	  a	  soft	  voice	  and	  
reduced	  intelligibility	  	  (Darley	  et	  al.,	  1969a;	  Darley	  et	  al.,	  1969b).	  Hawthorne	  effects	  
may	  weaken	  the	  agreement	  between	  clinical	  and	  environmental	  results.	  	  Although	  
patients	  are	  aware	  that	  their	  speech	  is	  being	  recorded	  in	  both	  settings,	  the	  focus	  on	  
speech	  recording	  in	  the	  clinical	  setting	  when	  the	  patient	  is	  reading	  sentences	  and	  
not	  formulating	  speech	  may	  differ	  from	  the	  natural	  environment.	  	  Listeners	  have	  
difficulty	  understanding	  those	  with	  dysarthric	  speech	  (K.	  K.	  Tjaden	  &	  Liss,	  1995),	  
and	  these	  complaints	  may	  not	  match	  the	  patient’s	  performance	  in	  a	  controlled	  
clinical	  environment	  when	  the	  patient	  is	  focused	  on	  performing	  to	  their	  maximum	  
capability	  (McCarney	  et	  al.,	  2007b).	  Others	  have	  suggested	  that	  patients	  with	  PD	  
may	  report	  less	  severe	  intelligibility	  problems	  than	  their	  communication	  partners	  	  
(Ho	  et	  al.,	  2000;	  Kalf	  et	  al.,	  2011;	  Miller	  et	  al.,	  2007).	  	  	  
Purpose.	  A	  study	  was	  developed	  to	  examine	  the	  effect	  of	  the	  environment	  on	  
spontaneous	  speech.	  
Hypotheses.	  Speech	  intelligibility	  and	  intensity	  would	  differ	  significantly	  
between	  clinical	  and	  natural	  environment	  settings,	  and	  the	  greater	  difference	  
between	  environments	  would	  be	  found	  in	  persons	  with	  PD.	  
Independent	  variable.	  Environment	  (clinic,	  home).	  
Dependent	  variables.	  Spontaneous	  speech	  intelligibility	  and	  intensity.	  




At	  least	  12	  participants	  with	  PD	  would	  be	  recruited	  and	  participate.	  A	  power	  
analysis	  was	  conducted	  based	  on	  pilot	  data	  from	  an	  undergraduate	  honor’s	  project	  
conducted	  by	  Lora	  Hellman	  in	  2012,	  entitled,	  “Comparison	  of	  Speech	  Amplitude	  and	  
Intelligibility	  Testing	  with	  Measures	  of	  Speech	  Communication	  in	  Daily	  Life	  in	  
Parkinson	  Disease.”	  	  Percent	  intelligibility	  in	  the	  clinical	  and	  natural	  environments	  
was	  measured	  in	  4	  participants	  with	  PD	  and	  one	  healthy	  control	  and	  found	  effect	  
size	  differences	  between	  the	  clinic	  and	  natural	  measures	  ranging	  from	  0.38	  to	  1.47	  
for	  intelligibility	  and	  0.41	  to	  1.8	  for	  intensity	  in	  the	  four	  patients.	  	  SYSTAT	  software	  
was	  used	  to	  compute	  the	  numbers	  of	  participants	  needed	  (Fig.	  1)	  for	  a	  power	  of	  0.80.	  
For	  percent	  intelligibility,	  11	  subjects	  would	  be	  required	  to	  find	  differences	  on	  
measures	  of	  speech	  intelligibility	  at	  p=0.025	  (Bonferroni	  corrected	  for	  2	  outcome	  
variables)	  between	  clinic	  and	  natural	  environment	  in	  the	  patient’s	  home.	  	  Further,	  
for	  sound	  pressure	  level	  change	  scores,	  8	  subjects	  would	  be	  required	  to	  find	  
significant	  differences	  at	  p=0.025	  (Fig.	  2).	  	  
Fig.1	  Power	  analysis	  using	  pilot	  test	  data	  on	  4	  PD	  patients	  on	  difference	  in	  
speech	  intelligibility	  






Difference	   Effect	  Size	   Alpha	   Power	  
Non-­‐Centrality	  
Parameter	  




Sample	  size	  (per	  cell)	   7	   8	   9	   10	   11	  
Power	   0.512	   0.606	   0.688	   0.757	   0.813	  
	  





Fig.	  2	  Using	  pilot	  test	  data	  on	  4	  PD	  patients	  on	  change	  in	  sound	  pressure	  level	  
	  






Difference	   Effect	  Size	   Alpha	   Power	  
Non-­‐Centrality	  
Parameter	  




Sample	  size	  (per	  cell)	   4	   5	   6	   7	   8	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Within	  group	  (clinic	  versus	  home	  environment)	  and	  between	  group	  (PD	  
versus	  HV)	  comparisons	  and	  their	  interactions	  were	  completed	  to	  examine	  speech	  
intelligibility	  and	  speech	  intensity	  (sound	  pressure	  level)	  in	  everyday	  life	  in	  13	  
persons	  with	  PD	  and	  a	  control	  group	  of	  12	  healthy	  volunteers	  with	  self-­‐reported	  
normal	  speech.	  Differences	  between	  speech	  intelligibility	  and	  speech	  intensity	  
(sound	  pressure	  level)	  in	  clinical	  testing	  versus	  natural	  environment	  and	  
interactions	  between	  group	  and	  environment	  were	  examined.	  
Subjects:	  	  Volunteer	  participants	  were	  recruited	  from	  area	  PD	  support	  
groups	  as	  well	  as	  via	  flyers	  and	  word	  of	  mouth	  in	  the	  community.	  	  Inclusion	  criteria	  
included:	  over	  50	  years	  of	  age,	  a	  score	  of	  23	  or	  higher	  on	  the	  Folstein	  Mini	  Mental	  
State	  Examination	  (MMSE)	  	  (Folstein,	  Folstein,	  &	  McHugh,	  1975),	  diagnosis	  of	  PD	  by	  
a	  neurologist,	  speech/voice	  impairment	  typical	  of	  hypophonia	  and/or	  dysarthria	  
commensurate	  with	  PD	  as	  judged	  by	  a	  practicing	  speech-­‐language	  pathologist	  with	  
experience	  in	  neurological	  disorders,	  typical	  hearing	  abilities,	  as	  demonstrated	  by	  
audiological	  screening	  at	  40	  dB	  at	  500,	  1000,	  2000,	  3000	  and	  4000	  Hz	  (allowing	  for	  
4000	  Hz	  notch	  if	  patient	  reports	  that	  they	  have	  experience	  shooting	  guns).	  	  
Exclusion	  critera	  include:	  history	  of	  voice	  or	  speech	  problems	  prior	  to	  PD	  diagnosis,	  
diagnosis	  of	  other	  neurological	  diseases	  other	  than	  PD,	  current	  diagnosis	  of	  mental	  
illness	  except	  depression,	  and	  non-­‐native	  American	  English	  speaker.	  	  Healthy	  
controls	  were	  recruited	  via	  word	  of	  mouth	  and	  JMU	  emails	  to	  faculty	  and	  staff.	  	  
Inclusion	  criteria	  for	  healthy	  controls	  were:	  50	  years	  old	  or	  older,	  typical	  hearing	  
abilities	  as	  demonstrated	  by	  an	  audiological	  screening	  at	  40	  dB	  at	  500,	  1000,	  2000,	  
3000	  and	  4000	  Hz	  (allowing	  for	  4000	  Hz	  notch	  if	  patient	  reports	  that	  they	  have	  
RUNNING	  HEAD:	  SPEECH	  FUNCTION	  IN	  PD;	  ENVIRONMENT,	  TASK,	  TREATMENT	  
	  
17	  
experience	  shooting	  guns),	  and	  an	  MMSE	  score	  of	  23	  or	  above.	  Exclusion	  criteria	  
included:	  presence	  of	  neurological	  diseases,	  any	  speech	  impairments,	  current	  
diagnosis	  of	  mental	  illness	  except	  depression,	  non-­‐native	  speakers	  of	  American	  
Standard	  English.	  	  All	  volunteers	  had	  telephone	  screening	  using	  the	  above	  criteria.	  
The	  MMSE	  and	  hearing	  screening,	  	  were	  administered	  on	  the	  first	  visit	  after	  the	  
consent	  process.	  
Tasks:	  All	  patients	  gave	  written	  consent	  in	  person	  prior	  to	  the	  start	  of	  the	  
session.	  	  Patients	  completed	  a	  health	  questionnaire	  and	  the	  Voice	  Handicap	  Index	  
(VHI)	  (Jacobson	  et	  al.,	  1997).	  	  Participants	  were	  then	  administered	  a	  hearing	  
screening	  and	  the	  Folstein	  Mini	  Mental	  State	  Examination	  (MMSE)	  	  (Folstein	  et	  al.,	  
1975).	  	  The	  following	  speech	  tasks	  were	  completed:	  conversation	  for	  a	  spontaneous	  
speech	  sample	  (Appendix	  1),	  the	  Sentence	  Intelligibility	  Test	  	  (Yorkston	  et	  al.,	  1996),	  
and	  a	  scripted	  recording	  that	  includes	  maximum	  phonation	  time,	  
maximum/minimum	  fundamental	  frequency,	  4	  different	  loudness	  levels	  on	  single	  
words,	  repeated	  glottal	  stops	  and	  voiceless	  consonants	  between	  vowels,	  stressed	  
words	  in	  sentences,	  intonation	  in	  sentences,	  and	  a	  counting	  task	  from	  60	  until	  the	  
patient	  runs	  out	  of	  air	  (for	  maximum	  phonation	  time	  in	  speech	  with	  voiced	  and	  
unvoiced	  sounds).	  	  The	  participants	  were	  then	  trained	  on	  the	  recording	  device.	  
Instruments	  and	  settings:	  	  Clinical	  recordings	  were	  made	  in	  a	  sound	  
attenuated	  room.	  	  A	  recording	  of	  the	  entire	  session	  was	  made	  with	  the	  LENA	  digital	  
language	  processor	  (DLP).	  	  The	  DLP	  collects	  data	  using	  an	  omnidirectional	  
microphone	  with	  a	  flat	  20-­‐20	  kHz	  frequency	  response.	  Frequencies	  above	  10	  kHz	  
are	  suppressed,	  as	  they	  are	  unlikely	  to	  contain	  human	  speech	  activity.	  Low	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frequency	  data	  are	  suppressed	  through	  a	  70	  Hz	  high-­‐pass	  filter.	  Anti-­‐aliasing	  
filtering	  is	  applied	  using	  10	  kHz	  low-­‐pass	  filter	  to	  suppress	  high-­‐frequency	  sounds	  
prior	  to	  digitization	  using	  a	  16	  kHz	  16-­‐bit	  sigma-­‐delta	  analog	  to	  digital	  (ADC)	  
converter	  with	  8x	  over-­‐sampling	  digital	  interpolation.	  When	  the	  LENA	  DLP	  was	  
tested	  with	  500Hz	  calibration	  tones	  in	  a	  sound	  attenuated	  room,	  the	  hardware	  
limiter	  for	  intensity	  suppression	  functionally	  activated	  at	  approximately	  87dbSPL.	  
This	  limiter	  was	  not	  expected	  to	  be	  problematic	  for	  the	  population	  of	  this	  study,	  
given	  that	  normal	  conversational	  speech	  hovers	  around	  60-­‐70dSPL	  at	  9	  inches	  mic-­‐
to-­‐mouth	  distance.	  	  When	  tested	  on	  various	  frequencies,	  the	  DLP	  showed	  response	  
to	  125	  Hz,	  250	  Hz,	  500	  Hz,	  750	  Hz,	  1000	  Hz,	  1500	  Hz,	  2000	  Hz,	  3000	  Hz,	  4000	  Hz,	  
6000	  Hz,	  and	  8000	  Hz.	  The	  DLP	  was	  placed	  on	  the	  participant	  at	  a	  9-­‐inch	  mouth-­‐to-­‐
microphone	  distance,	  clipped	  on	  their	  chest	  just	  below	  their	  mouth,	  to	  record	  
spontaneous	  speech	  and	  the	  assessment	  tasks.	  	  Natural	  environment	  recordings	  
were	  made	  in	  the	  participants’	  home	  and	  other	  settings.	  Researchers	  took	  care	  to	  
instruct	  patients	  on	  maintaining	  a	  microphone-­‐to-­‐mouth	  distance.	  	  They	  were	  
provided	  with	  a	  ribbon	  to	  measure	  this	  distance	  to	  maintain	  the	  same	  mouth-­‐to-­‐
microphone	  distance	  over	  the	  two	  days	  of	  recording.	  	  They	  were	  also	  provided	  with	  
basic	  instructions	  for	  making	  recordings	  with	  the	  DLP.	  
Calibration:	  The	  DLPs	  were	  calibrated	  using	  5	  calibration	  tones	  (65,	  70,	  75,	  
80	  and	  85	  dB	  SPL	  at	  500	  Hz).	  The	  tones	  were	  be	  delivered	  via	  Grason-­‐Stadler	  GSI	  61	  
clinical	  audiometer	  and	  factory	  Grason-­‐Stadler	  speakers	  in	  a	  sound	  attenuated	  room,	  
to	  the	  DLP	  and	  an	  SPL	  meter	  (set	  at	  50	  dB	  low,	  C-­‐weight,	  and	  fast	  speed)	  both	  9	  
inches	  from	  the	  speaker.	  	  These	  calibration	  recordings	  were	  saved	  for	  analysis	  when	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a	  linear	  interpolation	  was	  used	  to	  get	  the	  slope	  and	  y-­‐intercept	  of	  the	  calibration	  
recordings	  to	  be	  able	  to	  convert	  the	  dB	  into	  dB	  SPL.	  	  Calibration	  was	  recorded	  prior	  
to	  each	  participant	  in	  the	  same	  fashion.	  	  The	  basic	  linear	  interpolation	  graph	  for	  the	  
DLPs	  involved	  in	  this	  study	  is	  below.	  
Fig.	  3	  Basic	  linear	  interpolation	  graph	  for	  calibrating	  the	  recording	  devices	  
	  
Measures	  and	  Data	  Analysis:	  	  For	  the	  purposes	  of	  this	  study,	  the	  following	  
table	  demonstrates	  the	  data	  that	  was	  collected,	  the	  format	  for	  saving	  the	  data,	  
measures,	  and	  analysis.	  	  
	   	  
y	  =	  1.0447x	  -­‐	  9.146	  
R²	  =	  0.99971	  
y	  =	  1.0447x	  -­‐	  12.784	  































sound	  pressure	  level	  meter	  dBSPL	  
9	  in	  from	  speaker;	  SPL	  meter	  set	  to	  C-­‐weight,	  50	  dB	  low	  
DLP	  1	  
DLP	  2	  
Linear	  (DLP	  1)	  
Linear	  (DLP	  2)	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Table	  1:	  Data,	  format,	  measures	  and	  analysis	  for	  environment	  study	  





LENA	  DLP	   .wav	   Intensity	   Mean	  intensity	  of	  
utterance	  via	  
PRAAT	  
dB-­‐SPL	  processed	  via	  
linear	  interpolation	  from	  





tions	  of	  sentences	  









LENA	  DLP	   .wav	   Intensity	   Mean	  intensity	  of	  
utterance	  via	  
PRAAT	  
dB-­‐SPL	  processed	  via	  
linear	  interpolation	  from	  











Criteria	  for	  choosing	  spontaneous	  speech	  utterances	  in	  the	  clinical	  setting:	  
1. Participant’s	  attention	  must	  not	  have	  been	  on	  the	  recording	  device	  for	  
training	  or	  inquiry	  within	  1	  minute.	  	  For	  example,	  when	  reviewing	  the	  
recordings	  to	  sample	  spontaneous	  speech	  in	  the	  clinic,	  one	  minute	  before	  and	  
after	  any	  mention	  of	  the	  recording	  device,	  either	  for	  training	  proposes,	  
placement,	  or	  spontaneous	  comments	  or	  questions	  about	  the	  device,	  is	  excluded.	  
2. Participant	  must	  have	  been	  engaged	  in	  casual	  conversation	  and	  not	  
involved	  in	  an	  evaluative	  task.	  Any	  spontaneous	  utterances	  occurring	  during	  or	  
between	  evaluative	  tasks	  were	  excluded	  from	  the	  clinic	  spontaneous	  speech	  
sample	  that	  was	  analyzed.	  
3. Preferably,	  samples	  are	  taken	  during	  the	  interview	  portion	  at	  the	  
beginning	  of	  the	  session,	  prior	  to	  being	  familiarized	  with	  any	  evaluative	  tasks.	  	  
Patients	  give	  consent	  face	  to	  face	  prior	  to	  the	  session,	  so	  as	  soon	  as	  the	  session	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starts,	  the	  LENA	  is	  placed	  on	  the	  patient,	  and	  the	  researchers	  say,	  “This	  is	  the	  
recording	  device	  that	  we	  talked	  about	  and	  we	  will	  talk	  more	  about	  it	  at	  the	  end	  
of	  the	  session.”	  	  Researchers	  then	  go	  on	  to	  engage	  the	  participant	  in	  conversation	  
while	  they	  “just	  make	  a	  few	  notes,”	  so	  that	  the	  participant’s	  attention	  is	  not	  
directed	  towards	  the	  recording	  device.	  	  Researchers	  were	  careful	  to	  initiate	  
conversation	  about	  non-­‐voice/speech	  topics,	  such	  as	  grandchildren,	  how	  far	  the	  
patient	  had	  to	  drive,	  if	  they	  are	  planning	  to	  do	  anything	  while	  they	  are	  in	  town,	  
etc.	  	  A	  list	  of	  potential	  topics	  to	  initiate	  is	  provided	  for	  the	  researchers	  (Appendix	  
I).	  	  The	  intent	  is	  to	  match	  the	  natural	  environment	  as	  closely	  as	  possible	  with	  
regard	  to	  conversational	  topics	  and	  participant	  behavior.	  
4. Sentences	  were	  chosen	  based	  on	  similar	  length	  and	  complexity	  to	  
sentences	  in	  the	  Sentence	  Intelligibility	  Test	  (SIT)	  (Yorkston	  et	  al.,	  1996).	  
Spontaneous	  speech	  sentences	  were	  also	  drawn	  from	  the	  natural	  
environment,	  representative	  of	  conversational	  speech	  over	  2	  days	  in	  a	  16-­‐hour	  
sample	  (8	  hours	  each	  day),	  using	  the	  following	  procedures	  and	  criteria:	  
1. Condense	  the	  16-­‐hour	  file	  by	  removing	  all	  non-­‐speech	  sections,	  as	  
well	  as	  clinical	  tasks.	  
2. Make	  note	  of	  how	  many	  minutes	  remain	  (for	  example	  120	  minutes)	  
3. Using	  a	  random	  number	  generator,	  generate	  a	  list	  of	  numbers	  
representative	  of	  the	  number	  of	  minutes	  of	  speech	  in	  the	  reduced	  file	  (use	  
www.random.org)	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4. Choose	  the	  minute	  timestamp	  with	  the	  first	  random	  number,	  mark	  
with	  cursor	  and	  choose	  the	  closest	  sentence	  that	  the	  patient	  uttered	  from	  that	  
marker.	  	  Make	  a	  note	  of	  the	  timestamps	  of	  the	  beginning	  and	  end	  of	  this	  sentence.	  
5. Move	  to	  the	  next	  random	  number	  and	  repeat	  until	  there	  are	  12	  
sentences	  that	  meet	  the	  following	  criteria:	  
o Background	  noise	  is	  not	  louder	  than	  the	  target	  utterance.	  
o If	  background	  noise	  exists,	  it	  is	  consistent,	  for	  example,	  no	  
phone	  ringing	  in	  the	  middle	  of	  utterance.	  
o Conversational	  partner	  does	  not	  interject	  in	  the	  utterance.	  
o Sentences	  as	  a	  group	  fit	  the	  profile	  of	  the	  sentence	  
intelligibility	  test	  (4-­‐16	  words,	  use	  patient’s	  SIT	  stimuli	  for	  reference),	  
and	  are	  as	  similar	  as	  possible	  to	  the	  SIT	  sentences	  with	  regard	  to	  
grammatical	  complexity	  and	  intonation.	  	  
6. Continue	  to	  repeat	  the	  process	  with	  the	  random	  number	  generator	  
until	  12	  sentences	  are	  chosen	  that	  match	  closely	  to	  number	  of	  words	  and	  
grammatical	  complexity	  of	  SIT	  stimuli	  for	  that	  patient	  
Intelligibility	  tasks	  were	  recorded	  using	  the	  DLP	  and	  transferred	  to	  a	  digital	  
(.wav)	  file	  for	  analysis.	  Three	  different	  novel,	  inexperienced	  listeners	  transcribed	  
each	  speaker’s	  sentences,	  with	  no	  one	  listener	  hearing	  any	  repeated	  sentences.	  	  
Each	  volunteer	  listener	  passed	  a	  hearing	  screening	  (at	  30	  dB	  at	  500,	  1000,	  2000,	  
3000	  and	  4000	  Hz)	  and	  was	  limited	  to	  20	  minutes	  of	  listening	  to	  reduce	  listener	  
fatigue.	  	  They	  were	  provided	  with	  a	  laptop	  to	  transcribe	  what	  they	  hear	  as	  the	  
sentences	  are	  played	  for	  them,	  or	  they	  used	  their	  own	  laptop.	  	  Prior	  to	  playing	  each	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set	  of	  sentences,	  amplification	  levels	  on	  the	  speakers	  were	  set	  to	  match	  the	  same	  
sound	  pressure	  level	  meter	  values	  read	  during	  the	  calibration	  tone	  session,	  by	  
playing	  the	  calibration	  tones	  and	  reading	  the	  same	  sound	  level	  meter	  and	  adjusting	  
the	  amplification	  level	  so	  that	  the	  sound	  level	  meter	  reading	  for	  the	  calibration	  
tones	  match.	  	  Listeners	  were	  instructed	  that	  they	  would	  hear	  each	  sentence	  only	  
once	  and	  that	  they	  are	  to	  transcribe	  exactly	  what	  they	  hear,	  without	  regard	  for	  
punctuation.	  	  They	  are	  told	  not	  to	  make	  any	  corrections	  until	  the	  entire	  sentence	  is	  
transcribed,	  to	  reduce	  the	  load	  on	  memory.	  	  An	  Intraclass	  Correlation	  Coefficient	  
(ICC)	  revealed	  interrater	  reliability	  of	  .966,	  which	  exceeded	  our	  predetermined	  
minimum	  of	  0.65.	  	  Researchers	  transcribed	  the	  recordings	  according	  to	  the	  
guidelines	  in	  the	  SIT	  manual	  that	  lent	  a	  “percentage	  of	  intelligibility.”	  	  
Comparisons	  between	  the	  listener	  transcriptions	  and	  the	  key	  made	  by	  the	  
researchers	  were	  made	  with	  R,	  Package	  ‘qualV’	  	  (van	  den	  Boogaart,	  Rost,	  Petzoldt,	  &	  
Petzoldt,	  2014)	  using	  the	  Least	  Common	  Sequence	  (LCS)	  function	  algorithm.	  	  The	  
spreadsheet	  of	  all	  the	  responses	  was	  checked	  for	  spelling	  errors	  and	  then	  the	  LCS	  
program	  was	  applied	  to	  the	  responses.	  	  Text	  was	  converted	  to	  lowercase	  without	  
punctuation,	  erroneous	  spacing	  was	  removed,	  and	  the	  algorithm	  created	  output	  that	  
examined	  for	  the	  number	  of	  identical	  words	  in	  the	  same	  sequence	  as	  the	  key.	  	  This	  
number	  was	  divided	  by	  the	  greatest	  number	  in	  either	  sentence,	  accounting	  for	  
errors	  of	  omission	  and	  commission.	  	  The	  mean	  of	  each	  set	  of	  10	  sentences	  was	  taken,	  
multiplied	  by	  100	  and	  saved	  in	  the	  dataset.	  	  Reliability	  when	  compared	  to	  methods	  
outlined	  in	  the	  SIT	  for	  percent	  intelligibility	  ranged	  from	  R2=.98-­‐1.0.	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Intensity	  of	  the	  utterance	  was	  measured	  using	  Praat	  (Boersma	  &	  Weenink,	  
2010)	  software	  for	  speech	  analysis.	  Praat	  intensity	  settings	  were	  set	  to	  show	  a	  
range	  of	  25dB	  to	  100dB	  and	  “subtract	  mean	  pressure”	  was	  checked	  as	  OFF.	  	  The	  
vowel	  with	  peak	  amplitude	  in	  the	  sentence	  was	  selected	  and	  5	  cycles	  of	  that	  vowel	  
in	  which	  the	  peak	  intensity	  level	  is	  most	  stable	  was	  chosen.	  	  The	  sentence	  was	  
selected	  and	  if	  pauses	  exist	  greater	  than	  150	  ms,	  they	  were	  deleted.	  	  The	  mean	  
intensity	  over	  the	  utterance	  was	  recorded.	  	  	  The	  intensity	  level	  was	  converted	  into	  
decibels	  in	  sound	  pressure	  level	  re	  .0002	  dynes/cm2	  using	  the	  slope	  and	  y-­‐intercept	  
from	  the	  equation	  derived	  by	  measurement	  of	  calibration	  tones	  derived	  from	  the	  
same	  recording	  session	  for	  participant’s	  date,	  session	  and	  recording	  environment.	  	  	  
An	  example	  is	  listed	  below,	  “It	  was	  a	  blue	  bell.”	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Fig.	  5	  Analyzing	  intensity	  of	  a	  sentence	  via	  Praat	  
ɪt wəz ə blu bɛl 
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Fig	  5a.	  Select	  the	  sentence	  to	  be	  analyzed	  from	  the	  beginning	  to	  the	  end	  of	  the	  sound	  
contour.	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Fig.	  5b.	  Select	  “intensity”	  and	  “get	  intensity,”	  or	  read	  intensity	  in	  green	  from	  the	  right	  
side	  of	  the	  screen.	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Record,	  in	  this	  case,	  mean	  energy	  from	  selection	  is	  74.06	  dB.	  	  This	  value	  was	  
transformed	  via	  linear	  interpolation	  from	  calibration	  for	  that	  device	  and	  that	  day	  
into	  dB	  SPL.	  
Statistical	  Analysis:	  Two-­‐way	  repeated	  measures	  ANOVA	  compared	  clinic	  
versus	  natural	  environment	  (environment)	  within	  subjects	  and	  PD	  versus	  healthy	  
volunteers	  (group)	  between	  subjects	  and	  the	  interaction	  of	  environment	  and	  group.	  	  
Separate	  ANOVAs	  were	  conducted	  for	  each	  dependent	  variable:	  spontaneous	  speech	  
intelligibility,	  spontaneous	  speech	  intensity.	  	  Correlations	  were	  made	  to	  investigate	  
the	  contributions	  of	  years	  since	  diagnosis,	  depression,	  background	  noise,	  and	  how	  
intensity	  and	  intelligibility	  are	  related,	  as	  well	  as	  intelligibility	  between	  
environments.	  
Pilot	  data:	  A	  pilot	  study	  was	  completed	  after	  4	  participants.	  	  All	  data	  below	  
reflects	  spontaneous	  speech	  recorded	  via	  LENA	  DLP.	  	  Intensity	  data	  is	  in	  dB	  SPL	  
(transformed	  from	  raw	  intensity	  readings	  via	  linear	  interpolation	  of	  SPL	  readings	  of	  
calibration	  tones	  for	  that	  session).	  	  Intensity	  of	  speakers	  for	  intelligibility	  judges	  has	  
also	  been	  adjusted	  to	  match	  SPL	  readings	  for	  the	  day	  of	  the	  patient	  session.	  	  Please	  
note	  that	  the	  intensity	  pilot	  data	  below	  was	  taken	  from	  the	  stressed	  vowel	  in	  each	  
sentence.	  	  The	  analysis	  method	  changed	  after	  the	  pilot	  study	  to	  the	  above	  method	  of	  
mean	  intensity	  of	  the	  entire	  sentence,	  which	  we	  believe	  is	  more	  representative	  of	  
connected	  speech	  and	  also	  will	  more	  easily	  show	  a	  relationship	  to	  intelligibility	  of	  
the	  entire	  sentence.	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Fig.	  6.	  Pilot	  data	  for	  environment	  study	  
	  





































	   Intensity	   Intelligibility	  
	   in	  LAB	   in	  NAT	  ENV	   in	  LAB	   in	  NAT	  ENV	  
301	   69.23	   79.60	   	   68.10	  
302	   78.93	   83.80	   82.91	   82.66	  
303	   69.70	   82.10	   79.22	   59.00	  
304	   64.20	   68.80	   86.68	   95.60	  
mean	   70.52	   78.58	   82.94	   76.34	  




Pilot	  data	  showed	  that	  change	  in	  intelligibility	  measures	  between	  the	  clinical	  
measures	  and	  the	  natural	  environment	  varies	  between	  patients.	  	  
	  Overall	  the	  SPL	  of	  speech	  increased	  in	  the	  natural	  environment	  from	  the	  
clinic	  while	  no	  group	  trend	  was	  seen	  on	  percent	  intelligibility	  scores	  between	  the	  
clinic	  and	  the	  natural	  environment..	  Based	  on	  these	  three	  subjects	  intelligbility	  
observed	  in	  the	  clinical	  environment	  may	  not	  relate	  to	  intelligbility	  in	  the	  natual	  
environment.	  	  Also,	  it	  is	  worth	  noticing	  that	  patient	  304,	  with	  the	  lowest	  intensity	  
voice	  (in	  both	  envornments)	  is	  also	  the	  MOST	  intelligible	  (in	  both	  environments).	  	  
Conversely,	  patient	  303,	  with	  one	  of	  the	  higher	  intensity	  voices	  in	  the	  lab,	  is	  the	  
LEAST	  intelligible	  in	  the	  natural	  environment.	  
	  











0.08704	   0.08579	   0.04497	   0.21115	  
	  
Coefficients	  of	  variation	  indicate	  greatest	  variability	  between	  subjects	  in	  the	  
measure	  of	  intelligibility	  of	  spontaneous	  speech	  within	  the	  natural	  environment,	  
though	  variability	  of	  intelligibility	  in	  the	  clinical	  environment	  was	  comparatively	  
low.	  
Pilot	  data	  showed	  enough	  variance	  to	  more	  forward	  with	  the	  full	  study,	  
which	  is	  reviewed	  in	  the	  Manuscript	  section	  of	  this	  document.	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To	  explore	  which	  clinical	  task	  predicts	  speech	  intelligibility	  in	  the	  natural	  
environment.	  
Background.	  Standard	  clinical	  tasks	  for	  evaluation	  of	  hypophonia	  and	  
dysarthria	  reflect	  ASHA’s	  preferred	  practice	  patterns	  for	  speech-­‐language	  
pathologists	  (SLPs)	  	  (American	  Speech-­‐Language-­‐Hearing	  Association,	  2004)	  on	  
voice	  and	  motor	  speech	  assessments.	  	  These	  include:	  mean	  sound	  pressure	  level	  
(SPL)	  in	  prolonged	  vowel,	  range	  of	  SPL	  (SPL-­‐Δ),	  Consensus	  Auditory	  Perceptual	  
Evaluation	  of	  Voice	  (CAPE-­‐V)	  	  (Kempster	  et	  al.,	  2009),	  Sentence	  Intelligibility	  Test	  
(SIT)	  (Yorkston	  et	  al.,	  1996),	  maximum	  phonation	  time	  (MPT),	  harmonic	  to	  noise	  
ratio	  (HNR),	  and	  range	  of	  F0	  (F0-­‐Δ).	  	  Clinicians	  will	  also	  often	  include	  quality	  of	  life	  
scales	  such	  as	  the	  Voice	  Handicap	  Index	  (VHI)	  	  (Jacobson	  et	  al.,	  1997;	  C.	  A.	  Rosen,	  
Lee,	  Osborne,	  Zullo,	  &	  Murry,	  2004).	  The	  effects	  of	  task	  have	  been	  demonstrated	  
within	  the	  clinical	  environment	  	  (Ho,	  Iansek,	  &	  Bradshaw,	  1999;	  Huber	  &	  Darling,	  
2011).	  	  Clinical	  tasks	  have	  also	  been	  related	  to	  clinical	  ratings	  of	  speech	  clarity	  (Kim,	  
Kent,	  &	  Weismer,	  2011).	  	  To	  determine	  if	  previous	  studies	  have	  examined	  the	  
relationship	  between	  clinical	  measures	  and	  measure	  in	  the	  natural	  environment	  a	  
search	  was	  conducted	  on	  the	  PubMED	  and	  Scopus/Elsevier	  databases	  using	  the	  
following	  terms:	  “acoustic,	  speech,	  measures,	  conversation.”	  	  PubMED	  revealed	  23	  
articles,	  with	  3	  mentioning	  PD,	  one	  of	  which	  was	  regarding	  telerehabilitation.	  	  Of	  the	  
remaining	  two,	  the	  difference	  between	  acoustic	  measures	  of	  hypokinetic	  dysarthric	  
conversational	  speech	  and	  conversational	  speech	  of	  healthy	  controls	  was	  
investigated	  (K.	  M.	  Rosen	  &	  Duffy,	  2006),	  as	  well	  as	  the	  effect	  of	  task	  on	  volume	  (Ho	  
et	  al.,	  1999).	  	  Scopus/Elsevier	  revealed	  77,	  with	  3	  having	  “Parkinson”	  in	  their	  titles,	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one	  of	  which	  was	  regarding	  telerehabilitation.	  	  Of	  the	  remaining	  two,	  one	  examined	  
the	  effect	  of	  task	  on	  dysfluencies	  in	  PD	  speech,	  finding	  that	  dysfluencies	  were	  more	  
abundant	  in	  conversation	  than	  in	  other	  speech	  tasks	  (Van	  Lancker	  Sidtis,	  Cameron,	  
&	  Sidtis,	  2012).	  	  The	  other	  examined	  the	  effects	  of	  pallidotomy	  surgery	  on	  sentence	  
measures,	  also	  showing	  some	  differences	  in	  intelligibility	  between	  reading,	  picture	  
description,	  and	  conversation	  (G.	  Schulz,	  2004).	  
Problem.	  	  The	  clinical	  environment	  encourages	  patients	  to	  attend	  to	  how	  
they	  are	  talking,	  whereas	  spontaneous	  speech	  in	  the	  natural	  environment	  requires	  
patients	  to	  attend	  to	  what	  they	  are	  saying	  and	  not	  how	  they	  are	  talking	  (Connor	  &	  
Abbs,	  1991;	  Kempler	  &	  Lancker,	  2002).	  	  Patients’	  family	  members	  often	  complain	  of	  
problems	  with	  hearing	  and	  understanding	  their	  speech	  in	  their	  natural	  
environment;	  however,	  assessments	  take	  place	  in	  the	  clinical	  environment.	  	  Thus	  
task	  effect	  differences	  may	  play	  a	  role	  	  (Kempler	  &	  Lancker,	  2002;	  R.	  Kent	  et	  al.,	  
1989)	  as	  well	  as	  combination	  of	  speech	  and	  non-­‐speech	  tasks,	  such	  as	  what	  is	  seen	  
during	  conversational	  speech	  in	  the	  natural	  environment	  (Bunton	  &	  Keintz,	  2008).	  
In	  the	  study	  on	  environment	  (detailed	  in	  Manuscript	  section),	  we	  saw	  differences	  
between	  environments	  that	  were	  unexpected,	  such	  as	  increased	  speech	  intensity	  in	  
the	  home	  environment,	  and	  intelligibility	  unaffected	  by	  environment.	  	  Persons	  with	  
PD	  were	  set	  apart	  by	  decreased	  intelligibility	  compared	  to	  healthy	  controls,	  even	  
though	  the	  sample	  consisted	  of	  mild	  to	  moderately	  impaired	  persons.	  Initial	  
correlations	  between	  years	  since	  diagnosis,	  depression,	  and	  background	  noise	  with	  
intensity	  and	  intelligibility	  in	  the	  home	  were	  not	  significant.	  	  Only	  comparisons	  
between	  clinic	  spontaneous	  speech	  intelligibility	  and	  home	  spontaneous	  speech	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intelligibility	  were	  significant.	  	  However,	  there	  is	  not	  a	  standardized	  way	  to	  look	  at	  
spontaneous	  speech	  intelligibility	  in	  the	  clinic,	  therefore	  predictions	  can	  not	  be	  
made	  to	  spontaneous	  speech	  intelligibility	  in	  the	  home,	  the	  variable	  that	  sets	  apart	  
the	  participants	  with	  PD.	  	  Clinical	  tasks	  need	  to	  be	  explored	  to	  see	  if	  any	  typical	  
clinical	  task(s)	  might	  be	  predictive	  of	  spontaneous	  speech	  in	  the	  home.	  
Purpose.	  To	  explore	  the	  relationship	  of	  standard	  clinical	  measures	  to	  
intelligibility	  within	  the	  natural	  environment.	  These	  measures	  included	  mean	  sound	  
pressure	  level	  in	  prolonged	  vowel,	  Consensus	  Auditory	  Perceptual	  Evaluation	  of	  
Voice	  (CAPE-­‐V),	  Sentence	  Intelligibility	  Test	  (SIT),	  maximum	  phonation	  time,	  
harmonic	  to	  noise	  ratio,	  range	  of	  F0.	  	  Improved	  intelligibility	  in	  conversational	  
speech	  should	  be	  the	  primary	  aim	  for	  evaluation	  and	  treatment,	  and	  likely	  differs	  
from	  the	  usual	  clinical	  measures	  of	  voice	  	  (Deane	  et	  al.,	  2002).	  
Outcome	  variable.	  Spontaneous	  speech	  intelligibility	  in	  the	  natural	  
environment	  (SIHOME).	  
Predictor	  variables.	  Originally,	  the	  following	  were	  selected	  for	  inclusion	  in	  
our	  predictor	  variable	  set:	  mean	  sound	  pressure	  level	  (SPLVOWEL)	  in	  prolonged	  
vowel,	  range	  of	  SPL	  (SPL-­‐Δ),	  score	  on	  the	  Consensus	  Auditory	  Perceptual	  Evaluation	  
of	  Voice	  (CAPE-­‐V),	  percent	  intelligibility	  based	  on	  the	  Sentence	  Intelligibility	  Test	  as	  
analyzed	  via	  R	  (SITR),	  maximum	  phonation	  time	  (MPT),	  harmonic	  to	  noise	  ratio	  
(HNR),	  range	  of	  F0	  (F0-­‐Δ).	  	  After	  finding	  that	  SPL-­‐Δ	  and	  SPLVOWEL	  covaried	  (R2=.651),	  
SPL-­‐Δ	  was	  eliminated	  from	  our	  dataset.	  	  Additional	  inquiry	  into	  best	  practices	  for	  
range	  of	  F0	  led	  us	  to	  use	  the	  interquartile	  range	  of	  F0	  in	  targeted	  sentences	  (F0-­‐IQR)	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(Baken	  &	  Orlikoff,	  2000;	  Busso,	  Lee,	  &	  Narayanan,	  2009).	  	  Our	  final	  set	  of	  predictors	  
included:	  SITR,	  CAPE-­‐V,	  SPLVOWEL,	  HNR,	  MPT	  and	  F0-­‐IQR	  
Methods.	  
Subjects:	  Data	  was	  taken	  from	  the	  PD	  group	  in	  the	  aforementioned	  
environmental	  study.	  
Tasks:	  All	  patients	  gave	  consent	  in	  person	  prior	  to	  the	  start	  of	  the	  session.	  	  
Patients	  also	  filled	  out	  a	  health	  questionnaire	  and	  the	  Voice	  Handicap	  Index	  (VHI)	  
(Jacobson	  et	  al.,	  1997).	  	  Participants	  were	  administered	  the	  following	  in	  the	  clinical	  
environment:	  hearing	  screening,	  Folstein	  Mini	  Mental	  State	  Examination	  (MMSE)	  	  
(Folstein	  et	  al.,	  1975),	  engaged	  in	  conversation	  for	  spontaneous	  speech	  sample	  
(Appendix	  1),	  took	  the	  Sentence	  Intelligibility	  Test	  	  (Yorkston	  et	  al.,	  1996),	  and	  
followed	  a	  script	  recording	  that	  included	  tasks	  for	  measures	  of	  fundamental	  
frequency	  range,	  voice	  quality	  measures	  such	  as	  the	  harmonic	  to	  noise	  ratio	  
(Yumoto,	  Gould,	  &	  Baer,	  1982),	  maximum	  phonation	  time,	  measures	  of	  the	  intensity	  
dB	  SPL	  range	  when	  practicing	  4	  different	  loudness	  levels	  in	  speech,	  repeated	  glottal	  
stops	  between	  vowels	  and	  repeated	  voiceless	  consonants	  between	  vowels,	  	  stressed	  
words	  in	  sentences,	  intonation	  within	  sentences,	  and	  a	  counting	  task	  from	  60	  until	  
the	  patient	  runs	  out	  of	  air	  (for	  maximum	  phonation	  time	  in	  speech	  with	  voiced	  and	  
unvoiced	  sounds).	  	  	  
Instrumentation:	  	  Clinical	  recordings	  were	  made	  in	  a	  sound	  attenuated	  room.	  	  
A	  recording	  of	  the	  entire	  session	  was	  made	  with	  the	  LENA	  digital	  language	  
processor	  (DLP).	  	  The	  DLP	  settings	  remained	  the	  same	  as	  previously	  described.	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Calibration:	  As	  previously	  described,	  the	  DLP	  was	  calibrated	  using	  5	  
calibration	  tones,	  delivered	  via	  Grason-­‐Stadler	  GSI	  61	  clinical	  audiometer	  and	  
factory	  Grason-­‐Stadler	  speakers	  in	  a	  sound	  attenuated	  room,	  to	  the	  DLP	  and	  an	  SPL	  
meter	  (set	  at	  50	  dB	  low,	  C-­‐weight,	  and	  fast	  speed)	  distanced	  9	  inches	  from	  the	  
speaker.	  	  These	  calibration	  recordings	  were	  saved	  for	  analysis	  when	  a	  linear	  
interpolation	  was	  used	  to	  get	  the	  slope	  and	  y-­‐intercept	  of	  the	  calibration	  recordings	  
to	  be	  able	  to	  convert	  the	  dB	  into	  dB	  SPL.	  	  Calibration	  was	  ensured	  prior	  to	  each	  
participant	  in	  the	  same	  fashion.	  	  	  
Measures	  and	  Data	  Analysis:	  	  For	  the	  purposes	  of	  this	  exploration,	  the	  
following	  table	  lists	  the	  data	  collected	  (outcome	  variable	  is	  listed	  first),	  the	  format	  
for	  saving	  the	  data,	  measures,	  and	  analysis.	  	  Both	  perceptual	  and	  acoustic	  measures	  
were	  recorded	  using	  the	  LENA	  DLP	  for	  consistency.	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.wav	   range	  of	  F0	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  >	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  first	  to	  
last	  cycle	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  report	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mean	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  interquartile	  
range	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  standard	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  F0-­‐IQR	  
	  
• Intelligibility	  measurements	  (SIHOME,	  SICLINIC,	  SITR):	  Natural	  environment	  
spontaneous	  speech	  sentences	  were	  randomly	  selected	  from	  the	  natural	  
environment,	  representative	  of	  conversational	  speech	  over	  2	  days	  in	  a	  15-­‐
hour	  sample	  (7-­‐8	  hours	  each	  day),	  using	  the	  same	  procedures	  and	  criteria	  as	  
the	  environment	  study.	  	  SIT	  sentences	  were	  chosen	  via	  the	  SIT	  computer	  
program	  	  (Yorkston	  et	  al.,	  1996)	  Three	  novel	  listeners	  transcribed	  each	  
sentence	  using	  laptops	  and	  transcribing	  into	  a	  Microsoft	  Excel	  file.	  	  
Amplification	  levels	  on	  speakers	  matched	  the	  day	  of	  the	  recordings	  as	  
checked	  by	  sound	  pressure	  level	  meter.	  	  Comparisons	  of	  transcriptions	  were	  
made	  to	  a	  key	  that	  the	  researchers	  made	  (who	  were	  allowed	  to	  listen	  at	  
higher	  levels	  if	  needed	  and	  listen	  for	  context,	  an	  unlimited	  number	  of	  times).	  	  
The	  listener	  transcriptions	  and	  the	  key	  were	  compared	  via	  R,	  Package	  ‘qualV’	  
using	  the	  Least	  Common	  Sequence	  (LCS)	  algorithm	  (van	  den	  Boogaart	  et	  al.,	  
2014).	  	  Therefore,	  we	  indicated	  ‘SITR’	  for	  this	  variable	  as	  distinct	  from	  ‘SIT’	  
for	  the	  commercially	  available	  assessment.	  
• Mean	  sound	  pressure	  level	  (SPLVOWEL)	  prolonged	  vowel:	  The	  middle	  90%	  of	  
the	  prolonged	  vowel	  task	  was	  selected,	  mean	  intensity	  reading	  was	  recorded	  
from	  Praat	  (e.g.	  Fig.7),	  and	  transformed	  via	  linear	  interpolation	  from	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calibration	  recording.	  	  In	  the	  example	  below,	  Praat	  reads	  73.48	  dB,	  and	  this	  
value	  was	  transformed	  for	  the	  final	  value	  via	  the	  slope	  and	  y-­‐intercept	  from	  
the	  calibration	  exercise	  for	  LENA	  microphone	  at	  9	  inches	  from	  the	  mouth.	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Fig.	  7:	  Measuring	  SPLVOWEL	  
	  
• Consensus	  Auditory	  Perceptual	  Evaluation	  of	  Voice	  (CAPE-­‐V):	  Using	  the	  
CAPE-­‐V	  standard	  protocol	  (Kempster	  et	  al.,	  2009)	  a	  speech-­‐language	  
pathologist	  with	  training	  on	  this	  method	  determined	  the	  overall	  score	  out	  of	  
100.	  	  Expert	  clinician	  was	  given	  a	  digital	  recording	  with	  1-­‐2	  minutes	  of	  
conversation,	  SIT	  sentences,	  and	  the	  script	  recording	  of	  speech	  tasks.	  
• Maximum	  phonation	  time	  (MPT):	  Using	  Praat	  (Fig.9),	  from	  first	  to	  last	  cycle	  
of	  MPT	  task	  was	  selected,	  then	  voice	  report,	  number	  of	  seconds	  to	  the	  first	  
decimal	  place	  were	  recorded.	  In	  this	  example,	  the	  value	  was	  15.3	  seconds.	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Figure	  8:	  Measuring	  maximum	  phonation	  time
	  
• Harmonic	  to	  noise	  ratio	  (HNR):	  Using	  Praat,	  pulses	  were	  selected,	  then	  “show	  
pulses”	  and	  all	  pulses	  of	  vowel	  from	  sustained	  “ah”	  were	  selected,	  then	  voice	  
report,	  and	  mean	  harmonics-­‐to-­‐noise	  ratio	  was	  recorded.	  	  HNR	  was	  
expressed	  as	  dB,	  for	  example:	  if	  .98	  of	  the	  signal	  is	  periodic,	  HNR	  is	  
10*log10(98/1)=19.9	  dB	  
• Range	  of	  F0	  (F0-­‐IQR):	  Using	  PRAAT	  the	  entire	  sentence	  was	  selected,	  then	  the	  
mean	  pitch	  and	  standard	  deviation	  from	  each	  of	  the	  two	  sentence	  tasks	  was	  
recorded.	  	  Then	  using	  standard	  z	  scores,	  the	  mean	  and	  the	  standard	  
deviation,	  interquartile	  range	  was	  calculated,	  and	  an	  average	  over	  the	  two	  
tasks	  was	  taken.	  	  	  
Statistical	  Analysis:	  multiple	  regression.	  	  Outcome	  variable:	  SIHOME.	  	  Predictor	  
variables:	  SITR,	  CAPE-­‐V,	  SPLVOWEL,	  HNR,	  MPT	  and	  F0-­‐IQR.	  
Results	  are	  discussed	  in	  the	  manuscript	  portion	  of	  this	  document.	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To	  assess	  the	  effect	  of	  treatment	  on	  speech	  intelligibility	  and	  intensity	  in	  the	  
natural	  environment.	  
Background.	  In	  seeking	  a	  treatment	  protocol	  in	  which	  to	  apply	  pre-­‐post	  
measures	  within	  the	  natural	  environment	  via	  LENA	  technology,	  the	  SpeechVive™	  
stood	  out	  as	  a	  treatment	  that	  exists	  within	  the	  natural	  environment	  that	  potentially	  
functionally	  impacts	  intensity	  and	  intelligibility.	  	  Some	  literature	  has	  indicated	  
sensory	  deficits	  in	  PD	  as	  related	  to	  hypophonia	  	  (Fox	  et	  al.,	  2002;	  Hammer	  &	  Barlow,	  
2010),	  while	  others	  point	  to	  coordination	  across	  neurological	  subsystems	  for	  motor	  
execution	  	  (Stelmach	  et	  al.,	  1989).	  	  In	  the	  limb,	  fine	  motor	  movement,	  and	  gait	  
literature,	  external	  cues	  have	  been	  shown	  to	  benefit	  patients	  both	  from	  a	  sensory	  
and	  coordination	  perspective	  	  (Morris	  et	  al.,	  1994;	  Oliveira	  et	  al.,	  1997).	  	  Similar	  
principles	  may	  also	  affect	  respiration	  and	  voice	  	  (Sadagopan	  &	  Huber,	  2007).	  	  
Progressive	  reductions	  in	  articulatory	  movement	  occur	  throughout	  the	  disease	  
process	  in	  PD	  	  (Walsh	  &	  Smith,	  2012),	  which	  may	  make	  PD	  patients	  more	  reliant	  on	  
external	  cues	  for	  feedback.	  	  The	  SpeechVive™	  is	  a	  wearable	  device	  that	  delivers	  
cocktail	  chatter	  to	  one	  ear	  and	  thus	  elicits	  the	  Lombard	  Effect	  to	  speak	  more	  loudly	  
due	  to	  the	  addition	  of	  background	  noise	  	  (Pick	  &	  al.,	  1989).	  	  As	  previously	  discussed,	  
global	  treatment	  approaches	  to	  dysarthria	  in	  PD	  (i.e.	  rate	  reduction,	  increased	  
loudness,	  and	  clear	  speech)	  are	  those	  that	  extend	  across	  an	  entire	  utterance	  and	  
impact	  multiple	  speech	  components	  (i.e.	  respiration,	  phonation,	  articulation,	  
resonance)	  (Yorkston	  et	  al.,	  2007).	  These	  treatment	  techniques	  are	  intended	  to	  
improve	  intelligibility	  in	  dysarthria	  	  (Duffy,	  2012;	  Fox	  et	  al.,	  2002;	  Weismer	  et	  al.,	  
2012;	  Yorkston	  et	  al.,	  2007)	  by	  way	  of	  improving	  the	  multiple	  speech	  components,	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including	  phonation.	  Instruction	  to	  speak	  louder	  has	  resulted	  in	  increase	  jaw	  
movement	  	  (Connor	  et	  al.,	  1989;	  Connor	  &	  Abbs,	  1991)	  and	  increased	  respiration	  
(Huber	  &	  Darling,	  2011)	  in	  patients	  with	  PD.	  	  Principles	  of	  practice	  and	  exercise	  
physiology	  indicate	  that	  if	  someone	  practices	  heavier	  loading	  on	  the	  muscles	  he/she	  
will	  become	  stronger	  (Muller,	  1970;	  Taaffe	  et	  al.,	  1999).	  	  Currently	  Huber	  and	  
colleagues	  are	  evaluating	  whether	  12	  weeks	  use	  of	  the	  SpeechVive	  improves	  speech	  
intensity,	  intelligibility	  and	  other	  characteristics	  within	  the	  context	  of	  a	  multiple	  
single	  subject	  design.	  	  Speech	  is	  tested	  with	  and	  without	  the	  device,	  in	  the	  presence	  
of	  a	  speech	  pathologist,	  with	  a	  clinical	  setup	  within	  the	  home.	  	  	  
Problem.	  	  Pre-­‐	  and	  post-­‐	  test	  measures	  of	  spontaneous	  speech	  intelligibility	  
and	  intensity	  in	  the	  natural	  environment	  are	  not	  included	  within	  the	  current	  
SpeechVive™	  study.	  	  Huber	  and	  colleagues	  seek	  natural	  environment	  measures	  to	  
expand	  on	  the	  results	  from	  their	  clinical	  measures.	  	  
Purpose.	  	  To	  assess	  pre-­‐	  and	  post-­‐	  treatment	  measures	  of	  speech	  
intelligibility	  and	  intensity,	  within	  the	  natural	  environment,	  in	  tandem	  with	  the	  
SpeechVive™	  study,	  particularly	  carryover	  effects.	  	  To	  examine	  the	  advantages	  and	  
disadvantages	  of	  speech	  measurement	  in	  the	  natural	  environment	  for	  the	  purposes	  
of	  measuring	  progress.	  
Hypothesis.	  Application	  of	  the	  SpeechVive™	  device	  for	  12	  weeks	  will	  show	  
an	  increase	  in	  intelligibility	  and	  intensity	  in	  the	  natural	  environment.	  	  	  
Independent	  Factor.	  Treatment	  
Dependent	  variables.	  Spontaneous	  speech	  intelligibility,	  spontaneous	  
speech	  intensity.	  




Subjects:	  Subjects	  were	  recruited	  from	  the	  environment	  study,	  and	  7	  of	  the	  
13	  completed	  this	  treatment	  study.	  
Tasks:	  This	  study	  ran	  in	  tandem	  with	  the	  first	  study	  so	  the	  methodology	  is	  
the	  same	  with	  regards	  to	  sampling	  criteria	  and	  data	  collection	  with	  a	  few	  additions:	  	  
(a)	  participant	  will	  begin	  the	  SpeechVive™	  study	  no	  longer	  than	  a	  week	  after	  
completing	  the	  environment	  study,	  (b)	  participants	  will	  begin	  the	  treatment	  study	  
within	  24	  hours	  after	  wearing	  the	  device	  for	  12	  weeks,	  per	  the	  study,	  that	  is	  the	  
participants	  will	  end	  the	  SpeechVive™	  study	  and	  begin	  this	  study	  within	  24	  hours.	  
Instrumentation:	  	  As	  with	  the	  environment	  study,	  a	  recording	  of	  the	  entire	  
session	  was	  made	  with	  the	  LENA	  digital	  language	  processor	  (DLP).	  	  Refer	  to	  
previous	  information	  on	  specifications.	  
Calibration:	  As	  was	  previously,	  the	  DLP	  was	  calibrated	  using	  5	  calibration	  
tones,	  in	  a	  sound	  attenuated	  room,	  to	  the	  DLP	  and	  an	  SPL	  meter	  distanced	  9	  inches	  
from	  the	  speaker.	  	  These	  calibration	  recordings	  were	  saved	  for	  analysis	  when	  a	  
linear	  interpolation	  was	  used	  to	  get	  the	  slope	  and	  y-­‐intercept	  of	  the	  calibration	  
recordings	  to	  convert	  the	  dB	  into	  dB	  SPL.	  	  Calibration	  was	  ensured	  prior	  to	  each	  
participant	  in	  the	  same	  fashion.	  	  	  
Measures	  and	  Data	  Analysis:	  	  For	  the	  purposes	  of	  this	  study,	  table	  4	  
demonstrates	  the	  data	  that	  was	  collected	  (outcome	  variable	  is	  listed	  first),	  the	  
format	  for	  saving	  the	  data,	  measures,	  and	  analysis.	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.wav	   Intensity	   Mean	  intensity	  of	  
utterance	  via	  PRAAT	  
dB-­‐SPL	  processed	  via	  
linear	  interpolation	  
from	  caltone	  values	  
	  
• Intelligibility	  (SIHOME):	  Natural	  environment	  spontaneous	  speech	  sentences	  
was	  drawn	  from	  the	  natural	  environment,	  representative	  of	  conversational	  
speech	  over	  2	  days	  in	  a	  16-­‐hour	  sample	  (8	  hours	  each	  day),	  using	  the	  same	  
procedures	  and	  criteria	  as	  in	  the	  environment	  study.	  
• Sound	  pressure	  level	  of	  the	  sentence	  (SPLSENT):	  In	  similar	  fashion	  to	  mean	  
intensity	  reading	  the	  environment	  study,	  extract	  pauses	  >	  150ms,	  select	  
entire	  utterance,	  record	  mean	  intensity	  reading	  from	  PRAAT,	  and	  transform	  
via	  linear	  interpolation	  from	  the	  calibration	  recording.	  
Statistical	  Analysis:	  Repeated	  measures	  ANOVA	  will	  compare	  pre-­‐	  and	  post-­‐	  
treatment	  values	  of	  intelligibility	  and	  intensity	  in	  spontaneous	  speech	  within	  the	  
natural	  environment.	  
Pilot	  Data	  for	  a	  power	  analysis:	  Preliminary	  data	  on	  Intelligibility	  was	  not	  
available.	  Pre-­‐	  and	  post-­‐	  measures	  on	  dB	  SPL	  were	  available	  on	  only	  3	  patients.	  	  
Note:	  intensity	  values	  are	  from	  stressed	  vowel	  in	  each	  sentence,	  rather	  than	  the	  full	  
sentence.	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Table	  5:	  Pilot	  data	  for	  treatment	  study	  
	   Intensity	  
	   PRE	   POST	  
301	   75.9	   79.6	  
302	   83.8	   84.2	  
307	   88.1	   88.7	  
	  
	   The	  effect	  size	  for	  difference	  in	  dB	  pre	  and	  post	  is	  0.84.	  	  	  Using	  G	  power	  to	  do	  
a	  power	  analysis	  the	  results	  of	  the	  required	  N	  for	  aim	  3	  are	  11	  subjects	  (see	  below).	  	  
Seven	  subjects	  completed	  the	  study.	  	  Since	  our	  pre-­‐determined	  n	  was	  not	  achieved,	  
we	  wrote	  this	  up	  as	  an	  expanded	  pilot	  study	  for	  feasibility.	  	  The	  results	  are	  
discussed	  in	  the	  pilot	  study	  section	  of	  this	  document.	  
G Power 3.1 output 
 
t tests - Means: Difference between two dependent means (matched pairs) 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = One 
 Effect size dz = 0.84  
 α err prob = 0.05 
 Power (1-β err prob) = 0.80 
Output: Noncentrality parameter δ = 2.7859648 
 Critical t = 1.8124611 
 Df = 10 
 Total sample size = 11 




Inherent	  in	  the	  natural	  environment	  is	  variability.	  	  Some	  variables	  cannot	  be	  
controlled	  for,	  such	  as	  number	  and	  quality	  of	  communication	  partners,	  amount	  of	  
interaction,	  speaking	  environments	  (home,	  church,	  neighbor’s	  home,	  etc.)	  cues	  
within	  the	  natural	  environment	  that	  may	  enhance	  behaviors,	  or	  items	  in	  the	  natural	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environment	  that	  may	  inhibit	  certain	  behaviors.	  	  Several	  factors	  influence	  the	  voice	  
and	  speech	  production	  in	  persons	  with	  PD	  such	  as	  motor	  execution	  deficits,	  task	  
effects,	  cognition	  and	  linguistic	  processing	  demands.	  	  In	  addition	  disease	  factors	  and	  
ongoing	  neuropharmacological	  treatment	  can	  alter	  speech,	  as	  shown	  in	  what	  is	  our	  
Fig.	  9,	  below,	  but	  Fig.	  1	  in	  the	  original	  article	  (Goberman	  &	  Coelho,	  2002).	  	  	  
	  
Reductions	  in	  variance	  may	  occur	  when	  exploring	  the	  same	  natural	  
environment,	  within	  subjects,	  such	  as	  in	  the	  Pilot	  study	  (pre-­‐	  post-­‐treatment).	  	  It	  is	  
expected	  that	  the	  environments	  themselves	  vary;	  therefore	  differences	  between	  
groups	  may	  be	  more	  variable	  than	  individual	  differences	  pre-­‐	  and	  post-­‐	  within	  
subjects.	  	  However,	  this	  study	  may	  be	  limited	  in	  number	  of	  participants	  according	  to	  
device	  availability	  for	  the	  study.	  
Intelligibility	  may	  depend	  on	  other	  variables	  such	  as	  test	  material,	  personnel,	  
training,	  test	  procedures,	  and	  state	  of	  the	  speaker	  (R.	  Kent	  et	  al.,	  1989).	  	  The	  test	  
material	  and	  procedures	  are	  controlled	  in	  clinical	  assessment	  but	  they	  may	  be	  less	  
relevant	  in	  the	  natural	  environment.	  	  The	  use	  of	  speech	  for	  communication	  within	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the	  natural	  environment,	  in	  terms	  of	  functional	  intelligibility,	  is	  our	  variable	  of	  
interest.	  	  
Other	  limitations	  relevant	  in	  the	  natural	  environment	  is	  the	  time	  that	  
medication	  is	  taken	  relative	  to	  the	  recording,	  the	  patient’s	  feeling	  of	  fatigue	  and	  level	  
of	  distraction	  by	  preceding	  or	  concurrent	  events.	  Such	  “limitations”	  contribute	  to	  
the	  effect	  of	  the	  natural	  environment,	  within	  and	  between	  subjects.	  	  Limitations	  are	  
more	  fully	  discussed	  in	  the	  manuscript	  and	  pilot.	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Appendix	  I:	  List	  of	  potential	  conversational	  topics	  
• Home/Distance	  
o How	  was	  your	  trip	  over?	  
o Did	  it	  take	  long	  to	  get	  here?	  
o Did	  you	  find	  it	  okay?	  
• Family	  
o Do	  you	  have	  children?	  
o Do	  they	  live	  nearby?	  	  Do	  you	  get	  to	  see	  them	  often?	  
• Parkinson’s	  Disease	  
o Tell	  me	  a	  little	  about	  how	  you	  found	  out	  about	  your	  Parkinson’s	  
Disease.	  
• Work	  
o What	  do/did	  you	  do	  for	  work?	  	  Did	  you	  enjoy	  it?	  
• Hobbies	  
o What	  do	  you	  like	  to	  do	  for	  fun?	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Objective:	  To	  compare	  the	  effects	  of	  clinical	  and	  home	  environments	  on	  speech	  in	  
persons	  with	  Parkinson’s	  disease	  (PD)	  and	  healthy	  controls	  (HV).	  
Participants:	  Thirteen	  persons	  with	  PD	  and	  speech	  difficulty	  and	  a	  control	  group	  of	  
twelve	  healthy	  volunteers	  with	  normal	  speech	  were	  recorded.	  
Methods:	  A	  small	  portable	  digital	  recorder	  was	  used	  to	  record	  spontaneous	  
conversations	  of	  participants	  in	  both	  settings.	  	  Spontaneous	  speech	  intelligibility	  
and	  intensity	  were	  measured	  from	  sentences	  recorded	  during	  interactions	  in	  a	  clinic	  
setting	  and	  selected	  randomly	  from	  15	  hours	  of	  recordings	  made	  in	  the	  home.	  
Results:	  The	  PD	  group	  had	  reduced	  intelligibility	  compared	  to	  HV	  in	  both	  
environments	  (p=0.01)	  with	  no	  differences	  found	  between	  the	  clinic	  and	  home	  
environments.	  Groups	  did	  not	  differ	  in	  speech	  intensity	  but	  both	  had	  reduced	  
intensity	  in	  the	  clinic	  compared	  with	  home	  environment	  (p=0.02).	  This	  difference	  
was	  not	  correlated	  with	  environmental	  noise	  or	  articulation	  rate.	  	  Spontaneous	  
speech	  intelligibility	  in	  the	  clinic	  was	  related	  to	  spontaneous	  speech	  intelligibility	  in	  
the	  home	  environment	  (R2=0.309)	  in	  the	  PD	  group.	  	  	  
Conclusions:	  PD	  patients’	  speech	  intelligibility	  was	  equal	  to	  that	  measured	  in	  the	  
clinic,	  was	  decreased	  compared	  to	  healthy	  volunteers,	  and	  may	  reflect	  disease.	  	  
Possibly	  motivation	  to	  communicate	  with	  significant	  others	  contributed	  to	  speech	  
intensity	  increases	  in	  the	  home	  and	  may	  not	  reflect	  disease.	  	  
	   	  




Symptoms	  of	  Parkinson’s	  disease	  (PD)	  include	  resting	  tremor,	  reduced	  range	  
of	  movement	  (rigidity)	  and	  slow	  movement	  (bradykinesia)	  all	  of	  which	  affect	  motor	  
functions	  such	  as	  walking,	  speech	  and	  writing(1).	  All	  of	  the	  speech	  subsystems	  
(respiratory,	  laryngeal,	  and	  supralaryngeal)	  can	  be	  affected	  in	  persons	  with	  PD(2-­‐7).	  
Persons	  with	  PD	  usually	  suffer	  from	  hypokinetic	  dysarthria,	  which	  includes	  reduced	  
voice	  loudness,	  monoloudness,	  monopitch,	  disordered	  rate,	  disordered	  articulation,	  
hoarse,	  breathy,	  or	  harsh	  voice	  and/or	  tremulous	  voice	  (8,9).	  Symptoms	  may	  
change	  to	  hyperkinesia	  1-­‐hour	  post	  medication	  in	  some	  patients(10-­‐12).	  	  
Hypophonia	  accompanying	  PD	  is	  characterized	  by	  a	  soft	  voice	  and	  reduced	  
intelligibility(8,13).	  Overall,	  89%	  of	  those	  with	  PD	  have	  voice	  problems	  and	  45%	  
have	  articulation	  problems(9).	  	  
Reduced	  speech	  intensity	  has	  long	  been	  studied	  and	  treated	  in	  PD,	  as	  
hypophonia	  is	  a	  hallmark	  of	  the	  disease	  in	  many	  people	  with	  PD(14-­‐18).	  	  The	  most	  
commonly	  utilized	  therapy	  focuses	  on	  vocal	  loudness	  for	  changes	  in	  intensity	  and	  
posits	  that	  other	  speech	  subsystems	  benefit	  from	  the	  single	  task	  of	  increased	  
loudness(19).	  	  	  
Intelligibility	  is	  defined	  as	  “the	  degree	  to	  which	  the	  speaker’s	  intended	  
message	  is	  recovered	  by	  the	  listener”	  (20)	  and	  may	  depend	  upon	  both	  
communication	  task	  and	  environmental	  cues.	  	  Large	  differences	  in	  percent	  
intelligibility	  between	  spontaneous	  speech	  and	  reading	  aloud	  have	  been	  
reported(21).	  	  Significant	  differences	  between	  the	  intelligibility	  of	  single	  words,	  
sentences,	  and	  monologues	  have	  also	  been	  reported	  in	  persons	  with	  PD	  and	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dysarthria(22).	  	  Within	  the	  clinical	  environment	  (speech	  therapy	  office,	  rehab	  
setting,	  laboratory),	  the	  emphasis	  on	  speech	  may	  help	  the	  patient	  to	  focus	  on	  their	  
speech.	  For	  example,	  reading	  tasks	  may	  allow	  patients	  to	  concentrate	  solely	  on	  how	  
they	  are	  speaking.	  	  Patients	  are	  aware	  when	  their	  speech	  is	  being	  recorded,	  whether	  
at	  home	  or	  in	  the	  clinical	  environment,	  however	  the	  focus	  on	  speech	  in	  the	  clinical	  
environment	  while	  reading	  sentences	  may	  differ	  from	  communicating	  in	  the	  home	  
environment.	  	  Listeners	  have	  difficulty	  understanding	  those	  with	  dysarthric	  
speech(23).	  In	  a	  controlled	  clinical	  environment	  when	  the	  patient	  is	  focused	  on	  
performing	  to	  their	  maximum	  capability,	  their	  speech	  intelligibility	  may	  
improve(24).	  Patients’	  perception	  of	  their	  speech	  intelligibility	  may	  differ	  from	  their	  
listeners.	  	  Some	  have	  suggested	  that	  persons	  with	  PD	  may	  report	  that	  they	  have	  less	  
severe	  intelligibility	  problems	  than	  their	  communication	  partners	  report	  from	  
listening	  to	  them	  in	  the	  home	  environment(25-­‐27).	  Improved	  speech	  intelligibility	  is	  
the	  primary	  aim	  of	  treatment;	  however,	  this	  has	  not	  been	  measured	  as	  often	  as	  
speech	  intensity	  after	  treatment	  for	  PD(28).	  
Differences	  in	  speech	  produced	  in	  the	  clinic	  versus	  speech	  communication	  in	  
the	  natural	  or	  home	  environment	  for	  speakers	  with	  PD	  have	  been	  suggested	  in	  the	  
literature(29-­‐31).	  These	  differences	  may	  be	  due	  to	  differences	  in	  cognitive	  load,	  
performance	  effects,	  competition	  for	  cognitive	  resources,	  and	  environmental	  cues	  in	  
the	  two	  environments.	  In	  the	  home	  environment	  the	  speaker	  needs	  to	  focus	  on	  
functional	  communication,	  which	  may	  increase	  cognitive	  load(32)	  and	  distract	  
attention	  from	  speech.	  In	  2006,	  Burton	  et	  al.	  (33)	  observed	  that	  speakers	  with	  PD	  
were	  judged	  to	  be	  more	  intelligible	  during	  clinical	  tasks	  than	  in	  the	  natural	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environment	  by	  their	  spouses.	  	  During	  a	  dual	  task	  when	  persons	  were	  asked	  to	  read	  
sentences	  while	  screwing	  in	  a	  bolt	  with	  their	  non-­‐dominant	  hand,	  the	  patients	  had	  
lower	  sentence	  intelligibility	  scores,	  comparable	  to	  their	  spontaneous	  speech,	  
compared	  to	  a	  speech-­‐only	  condition.	  	  Environmental	  cues	  have	  been	  shown	  to	  
improve	  motor	  and	  speech	  functions	  in	  PD(6,34,35).	  	  
Given	  the	  described	  differences	  between	  environments	  and	  that	  judgments	  
are	  made	  clinically	  based	  on	  the	  clinical	  environment	  alone,	  exploration	  into	  the	  
relationship	  between	  clinical	  measures	  and	  the	  home	  environment	  may	  have	  
explanatory	  value	  and	  important	  implications	  for	  clinical	  practice.	  
Standard	  clinical	  tasks	  for	  evaluation	  of	  hypophonia	  and	  dysarthria	  in	  PD	  
include	  both	  acoustic	  measures,	  such	  as:	  mean	  sound	  pressure	  level	  (SPL)	  on	  a	  
prolonged	  vowel(19),	  range	  of	  SPL	  (SPL-­‐Δ)	  (36),	  maximum	  phonation	  time	  (MPT)	  
(37),	  harmonic	  to	  noise	  ratio	  (HNR)	  (38),	  and	  range	  of	  F0(39);	  and	  perceptual	  
measures	  such	  as:	  the	  Consensus	  Auditory	  Perceptual	  Evaluation	  of	  Voice	  (CAPE-­‐V)	  
(40)	  and	  the	  Sentence	  Intelligibility	  Test	  (SIT)	  (41).	  Clinicians	  often	  include	  quality	  
of	  life	  scales	  such	  as	  the	  Voice	  Handicap	  Index	  (VHI)	  (42,43).	  	  
SPL	  is	  usually	  measured	  by	  taking	  the	  mean	  intensity	  over	  the	  vocalized	  
portion	  of	  the	  sustained	  vowel,	  usually	  /a/	  or	  /i/(44),	  while	  F0-­‐range	  can	  be	  
measured	  either	  in	  sentences	  or	  from	  pitch	  glides.	  	  As	  males	  and	  females	  differ	  in	  
total	  F0	  range,	  using	  the	  interquartile	  range	  over	  a	  target	  sentence	  is	  thought	  to	  
correct	  for	  gender	  differences(45).	  MPT	  is	  measured	  from	  the	  vocal	  onset	  to	  offset	  
during	  a	  sustained	  phonation	  task(46).	  	  HNR	  is	  calculated	  from	  sustained	  phonation	  
and	  can	  be	  expressed	  in	  dB,	  for	  example	  if	  99%	  of	  the	  energy	  in	  the	  signal	  is	  in	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harmonics,	  and	  1%	  is	  noise	  between	  harmonics,	  the	  HNR	  is	  10*log10(99/1)-­‐
20dB(47).	  
Acoustic	  measurements	  such	  as	  SPL	  have	  been	  associated	  with	  increased	  
intelligibility	  in	  patients	  with	  PD(44,48).	  Although	  HNR	  has	  not	  yet	  been	  directly	  
studied	  in	  its	  relationship	  to	  intelligibility	  (PubMed	  search:	  “intelligibility	  AND	  HNR”	  
reveals	  5	  articles,	  none	  with	  direct	  relationships	  investigated),	  the	  GRBAS	  scale,	  a	  
perceptual	  measure	  of	  voice(49,50)	  has	  been	  correlated	  with	  intelligibility.	  	  The	  
more	  severe	  the	  GRBAS	  rating,	  the	  lower	  the	  intelligibility,	  despite	  intact	  
articulation	  and	  prosody(51).	  	  Perceptual	  measures	  such	  as	  the	  CAPE-­‐V	  and	  the	  SIT	  
are	  also	  common	  evaluative	  measures	  for	  persons	  with	  PD.	  	  The	  CAPE-­‐V(40)	  is	  
similar	  to	  GRBAS	  but	  was	  developed	  to	  standardize	  perceptual	  ratings	  of	  voice.	  	  As	  
patients	  are	  rated	  on	  spontaneous	  conversation	  and	  several	  speech	  tasks,	  
intelligibility	  may	  contribute	  to	  perceptual	  ratings.	  	  The	  Sentence	  Intelligibility	  Test	  
(SIT)	  records	  patients	  reading	  sentences	  of	  increasing	  length	  and	  then	  generates	  a	  
percent	  intelligibility	  based	  on	  three	  listeners’	  transcriptions	  of	  those	  sentences(41).	  	  
As	  the	  SIT	  uses	  connected	  speech	  tasks,	  it	  is	  thought	  to	  be	  relevant	  to	  spontaneous	  
connected	  speech.	  	  	  
Task	  effects	  have	  been	  demonstrated	  within	  the	  clinical	  environment	  (5,52)	  
(5,59)	  by	  changing	  situational	  cues	  and	  noting	  intensity	  changes(52),	  and	  between	  
extemporaneous	  and	  read	  speech	  tasks,	  and	  by	  noting	  linguistic	  and	  respiratory	  
changes(5).	  	  Clinical	  tasks	  have	  also	  been	  related	  to	  clinical	  ratings	  of	  speech	  
clarity(53).	  Because	  information	  on	  how	  clinical	  tasks	  relate	  to	  intelligibility	  in	  the	  
home	  were	  not	  found	  in	  the	  literature,	  the	  present	  study	  aimed	  to	  examine	  the	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relationship	  between	  the	  most	  common	  clinical	  tasks	  and	  speech	  intelligibility	  in	  the	  
home	  environment.	  	  
Intelligibility	  in	  the	  clinical	  environment	  is	  usually	  judged	  either	  informally	  
during	  the	  interview	  process	  (spontaneous	  speech),	  using	  a	  perceptual	  rating	  scale	  
like	  the	  CAPE-­‐V	  (spontaneous	  speech	  given	  prompt),	  or	  formally	  using	  a	  measure	  
like	  the	  SIT	  (reading	  task).	  	  CAPE-­‐V	  overall	  score	  interrater	  reliability	  has	  been	  
shown	  to	  be	  .76(54)	  and	  the	  SIT	  can	  show	  15%	  variability	  between	  listeners(55).	  	  
Still,	  these	  connected	  speech	  tasks	  and	  perceptual	  judgments	  are	  the	  closest	  
representation	  that	  we	  have	  of	  what	  happens	  in	  the	  home	  environment	  between	  
speaker	  and	  listener.	  	  No	  quantitative	  measures	  have	  reported	  on	  speech	  
intelligibility	  in	  the	  home.	  
In	  this	  study,	  we	  sought	  to	  compare	  spontaneous	  speech	  during	  
communication	  in	  the	  home	  environment	  with	  spontaneous	  speech	  in	  a	  clinical	  
environment.	  	  It	  was	  hypothesized	  that	  both	  speech	  intensity	  and	  speech	  
intelligibility	  would	  be	  greater	  in	  the	  clinical	  environment	  when	  compared	  to	  the	  
home	  environment,	  in	  both	  persons	  with	  PD	  and	  healthy	  controls.	  	  It	  was	  further	  
hypothesized	  that	  the	  greater	  difference	  between	  environments	  would	  be	  found	  in	  
persons	  with	  PD.	  	  We	  also	  aimed	  to	  explore	  typical	  clinical	  measures	  and	  how	  they	  
may	  relate	  to	  percent	  sentence	  intelligibility	  in	  the	  home	  environment	  (SIHOME).	  	  	  
Methods	  
James	  Madison	  University’s	  Institutional	  Review	  Board	  (IRB)	  and	  Sentara	  
Rockingham	  Memorial	  Hospital’s	  IRB	  approved	  the	  protocol	  for	  this	  study,	  including	  
the	  consent	  and	  all	  recruitment	  materials.	  




Participants	  were	  recruited	  through	  word-­‐of-­‐mouth,	  flyers,	  local	  PD	  support	  
groups,	  and	  Sentara	  Rockingham	  Memorial	  Hospital	  Voice	  and	  Swallowing	  Services.	  	  
Healthy	  controls	  were	  recruited	  in	  the	  same	  way	  and	  through	  email	  blasts	  to	  staff	  at	  
James	  Madison	  University.	  	  A	  phone	  screening	  was	  used	  to	  determine	  inclusion	  in	  
the	  study.	  	  Informed	  consent	  was	  sent	  to	  all	  included	  participants	  ahead	  of	  time	  for	  
informational	  purposes,	  and	  was	  reviewed	  and	  signed	  at	  the	  time	  of	  their	  
appointment.	  	  
Inclusion	  criteria	  for	  the	  PD	  group	  were:	  over	  50	  years	  of	  age,	  a	  score	  of	  23	  or	  
higher	  was	  required	  on	  the	  Folstein	  Mini	  Mental	  State	  Examination	  (MMSE)	  (56),	  
diagnosis	  of	  PD	  by	  a	  neurologist,	  speech/voice	  impairment	  typical	  of	  hypophonia	  
and/or	  dysarthria	  commensurate	  with	  PD	  as	  judged	  by	  a	  practicing	  speech-­‐
language	  pathologist	  with	  experience	  in	  neurological	  disorders,	  and	  passing	  an	  
audiological	  screening	  at	  40	  dB-­‐HL	  at	  500,	  1000,	  2000,	  3000	  and	  4000	  Hz	  (allowing	  
for	  a	  4000	  Hz	  notch	  in	  one	  ear,	  if	  the	  participant	  had	  experience	  with	  firearms).	  	  
Exclusion	  critera	  for	  the	  PD	  group	  included:	  history	  of	  voice	  or	  speech	  problems	  
prior	  to	  PD	  diagnosis,	  diagnosis	  of	  neurological	  disease(s)	  other	  than	  PD,	  current	  
diagnosis	  of	  mental	  illness	  except	  depression,	  and	  a	  non-­‐native	  Standard	  American	  
English	  speaker.	  	  	  
	   Inclusion	  criteria	  for	  the	  HV	  group	  were	  identical	  with	  the	  exception	  of	  
having	  the	  PD	  diagnosis.	  	  Exclusion	  criteria	  for	  the	  HV	  group	  were	  identical	  except	  
that	  they	  were	  without	  an	  adult	  history	  of	  speech	  problems.	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   Participants	  with	  PD	  were	  encouraged	  to	  make	  their	  appointments	  at	  a	  time	  
of	  day	  that	  was	  best	  for	  them,	  given	  their	  experience	  with	  their	  medication	  schedule.	  	  
HV	  made	  appointments	  at	  their	  convenience.	  	  Both	  groups	  tended	  to	  choose	  mid-­‐	  to	  
late-­‐	  morning	  appointments,	  usually	  within	  1-­‐2	  hours	  after	  medication.	  	  No	  
participants	  with	  PD	  exhibited	  dyskinesias	  at	  the	  time	  of	  the	  testing.	  
Listeners	  
Listeners	  were	  recruited	  from	  communication	  sciences	  and	  disorders	  classes	  
at	  James	  Madison	  University.	  	  Listeners	  volunteered	  their	  time	  and	  gave	  informed	  
consent.	  	  Inclusion	  criteria	  for	  the	  listener	  group	  included:	  Normal	  hearing	  (able	  to	  
pass	  audiological	  screening	  at	  30	  dB-­‐HL	  for	  500,	  1K,	  2K,	  3K,	  and	  4K	  Hz),	  and	  native	  
speaker	  of	  Standard	  American	  English.	  	  Exclusion	  criteria	  were:	  presence	  of	  disease,	  
delay	  or	  disorder	  affecting	  listening	  or	  attending	  to	  task.	  
Speech	  Recording	  	  	  
Clinical	  recordings	  were	  made	  in	  a	  sound	  attenuated	  room.	  	  Average	  
background	  noise	  was	  35	  dB-­‐SPL,	  measured	  using	  a	  Quest	  Model	  2200	  sound	  level	  
meter	  in	  the	  center	  of	  the	  room.	  	  The	  entire	  session	  was	  recorded	  using	  the	  LENA	  
digital	  language	  processor	  (DLP)	  (57)	  placed	  9	  inches	  from	  the	  mouth	  (Fig.	  1).	  The	  
DLP	  contains	  an	  omnidirectional	  microphone	  with	  a	  flat	  20-­‐20	  kHz	  frequency	  
response.	  Frequencies	  above	  10	  kHz	  are	  suppressed,	  as	  they	  are	  unlikely	  to	  contain	  
human	  speech.	  Low	  frequencies	  are	  suppressed	  by	  a	  70	  Hz	  high-­‐pass	  filter.	  Digital	  
data	  were	  filtered	  using	  a	  10	  kHz	  low-­‐pass	  filter	  to	  suppress	  high-­‐frequency	  sounds.	  
Acoustic	  waveforms	  were	  recorded	  using	  a	  16	  kHz	  16-­‐bit	  sigma-­‐delta	  analog	  to	  
digital	  (ADC)	  converter	  with	  8x	  over-­‐sampling	  digital	  interpolation.	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The	  LENA	  DLP	  has	  a	  hardware	  limiter	  for	  intensity	  suppression	  at	  87dbSPL.	  
This	  limiter	  was	  not	  problematic	  for	  this	  study,	  given	  that	  normal	  conversational	  
speech	  averaged	  79	  dB-­‐SPL	  with	  the	  mic-­‐to-­‐mouth	  distance	  set	  at	  9	  inches.	  	  No	  
clipping	  was	  observed	  in	  the	  sentence	  samples	  that	  were	  gathered.	  	  When	  tested	  on	  
pure	  tones	  at	  various	  frequencies,	  the	  DLP	  showed	  an	  equal	  flat	  response	  at	  125	  Hz,	  
250	  Hz,	  500	  Hz,	  750	  Hz,	  1000	  Hz,	  1500	  Hz,	  2000	  Hz,	  3000	  Hz,	  4000	  Hz,	  6000	  Hz,	  and	  
8000	  Hz.	  
The	  DLP	  was	  calibrated	  using	  500	  Hz	  calibration	  tones	  at	  65,	  70,	  75,	  80	  and	  
85	  dB-­‐HL.	  The	  tones	  were	  delivered	  via	  Grason-­‐Stadler	  GSI	  61	  clinical	  audiometer	  
and	  Grason-­‐Stadler	  speakers	  in	  a	  sound	  attenuated	  room.	  The	  DLP	  and	  a	  sound	  level	  
meter	  (set	  at	  50	  dB	  low,	  C-­‐weight,	  and	  fast	  speed)	  were	  both	  9	  inches	  from	  the	  
speaker.	  	  The	  SPL	  was	  read	  on	  the	  sound	  level	  meter	  while	  calibration	  recordings	  
were	  saved	  for	  linear	  interpolation	  to	  convert	  into	  dB-­‐SPL	  using	  Praat(58).	  	  
The	  slopes	  and	  y-­‐intercepts	  derived	  from	  the	  linear	  interpolation	  for	  each	  of	  
the	  two	  DLPs	  used	  for	  the	  study	  were:	  (DLP	  1,	  slope=1.0447,	  y-­‐intercept=9.146,	  
R2=.9997;	  DLP	  2,	  slope=1.0447,	  y-­‐intercept=12.784,	  R2=.9997).	  
The	  DLP	  was	  clipped	  on	  participants’	  chests	  9	  inches	  below	  their	  mouth,	  to	  
record	  spontaneous	  speech	  and	  the	  assessment	  tasks	  in	  the	  clinical	  setting	  (Fig.	  1).	  	  
Speech	  Tasks	  	  	  
Clinical	  sessions	  began	  with	  reviewing	  consent,	  placing	  the	  LENA-­‐DLP	  on	  the	  
participant	  at	  9	  inches	  from	  their	  mouth	  to	  start	  recording,	  followed	  by	  casual	  
conversation.	  Topics	  were	  either	  initiated	  by	  the	  participant	  or	  taken	  from	  a	  list	  of	  
topics	  that	  the	  researcher	  initiated,	  such	  as,	  “Did	  you	  have	  to	  travel	  far	  today?”	  and,	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“Does	  your	  family	  live	  nearby?	  Do	  you	  get	  to	  see	  them	  often?”	  	  This	  recording	  of	  
spontaneous	  conversation	  provided	  a	  clinical	  recording	  of	  at	  least	  5	  minutes	  that	  
could	  be	  contrasted	  with	  speech	  conversation	  in	  the	  home.	  
The	  Voice	  Handicap	  Index	  (VHI)	  (42,43)	  and	  Beck	  Depression	  Inventory	  
(BDI)	  (59)	  were	  administered	  as	  paper	  and	  pencil	  tests.	  	  Participants	  then	  
participated	  in	  a	  hearing	  screening	  and	  the	  MMSE	  (56).	  Participants	  were	  excluded	  
if	  they	  did	  not	  pass	  the	  hearing	  screening	  at	  40	  dB-­‐SPL	  (allowing	  for	  high	  frequency	  
loss	  at	  40K	  Hz	  in	  one	  ear),	  and/or	  if	  they	  didn’t	  score	  at	  least	  23	  points	  on	  the	  MMSE.	  
Instructions	  were	  given	  for	  formal	  speech	  testing,	  which	  included	  the	  Sentence	  
Intelligibility	  Test	  (41)	  and	  a	  script	  recording	  of	  speech	  tasks.	  	  The	  script	  recording	  
included	  tasks	  and	  examples	  to	  produce	  a	  sustained	  vowel	  and	  MPT.	  	  To	  measure	  F0	  
range	  in	  sentences,	  two	  phrases	  were	  imitated,	  “Say,	  that’s	  excellent,”	  and	  “No,	  he	  
meant	  you.”	  The	  script	  included	  other	  tasks	  not	  measured	  for	  the	  present	  study.	  	  	  
After	  speech	  testing	  was	  completed,	  the	  participants	  were	  instructed	  on	  the	  
LENA-­‐DLP,	  recording	  instructions.	  	  Participants	  were	  given	  written	  instructions	  for	  
device	  use	  and	  a	  letter	  to	  inform	  any	  other	  conversational	  partners	  that	  they	  may	  
encounter	  during	  the	  study	  about	  the	  recording.	  	  They	  were	  instructed	  on	  how	  to	  
switch	  the	  device	  on	  and	  off	  should	  they	  or	  their	  conversational	  partner	  wish	  to	  
have	  a	  private	  conversation.	  They	  were	  instructed	  not	  to	  use	  the	  DLP	  in	  the	  
presence	  of	  others	  not	  aware	  that	  the	  device	  was	  recording	  or	  did	  not	  agree	  to	  have	  
their	  speech	  recorded.	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All	  of	  the	  clinical	  recording	  sessions	  were	  collected	  by	  the	  same	  
experimenter	  at	  a	  time	  of	  day	  that	  the	  patient	  determined	  was	  “best”	  for	  them,	  given	  
their	  experience	  with	  their	  own	  medication	  schedule.	  	  	  
Recordings	  in	  the	  Home	  Environment	  
	  Recordings	  in	  the	  natural	  environment	  were	  made	  in	  the	  participants’	  home	  
and	  other	  non-­‐clinical	  settings	  in	  which	  their	  primary	  conversational	  partner	  was	  
usually	  their	  spouse,	  with	  prior	  agreement	  of	  the	  partner.	  	  Participants	  were	  
instructed	  on	  maintaining	  a	  9-­‐inches	  microphone-­‐to-­‐mouth	  distance	  and	  given	  a	  
ribbon	  to	  maintain	  the	  same	  mouth-­‐to-­‐mic	  distance	  over	  the	  two	  days	  of	  recording.	  	  
They	  were	  also	  provided	  with	  written	  instructions	  on	  making	  recordings	  with	  the	  
DLP.	  Participants	  then	  completed	  15	  hours	  of	  recording	  within	  their	  home	  
environment	  over	  two	  days.	  	  	  
Spontaneous	  utterances	  from	  the	  clinical	  session	  and	  the	  home	  environment	  
were	  reduced	  to	  conversational	  segments,	  time	  stamped,	  and	  selected	  via	  a	  random	  
number	  generator.	  	  Spontaneous	  utterances	  were	  selected	  from	  the	  sound	  file	  by	  
matching	  the	  random	  number	  generator	  to	  timestamps	  on	  the	  recording.	  	  The	  
nearest	  sentence	  within	  a	  conversation	  that	  met	  the	  following	  criteria	  was	  selected:	  
From	  intentional	  1-­‐on-­‐1,	  person-­‐to-­‐person	  communication,	  between	  4	  and	  15	  
words	  long	  without	  background	  noise	  interfering	  with	  speech	  and	  a	  unique	  
sentence.	  	  Sentences	  were	  excluded	  if:	  the	  conversation	  was	  with	  more	  than	  one	  
person;	  the	  conversational	  partner	  was	  not	  aware	  they	  were	  being	  recorded;	  the	  
sentence	  was	  too	  long	  for	  listeners’	  memory	  during	  transcription	  (>15	  words);	  or	  
was	  a	  repeated	  sentence.	  	  Ten	  randomly	  selected	  sentences	  from	  each	  environment	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were	  saved	  in	  a	  digital	  audio	  file	  (.wav)	  for	  further	  intelligibility	  and	  intensity	  
analysis.	  
Audio	  files	  of	  clinical	  tasks	  included:	  sustained	  vowel	  at	  comfortable	  pitch	  
and	  loudness,	  sustained	  vowel	  for	  maximum	  phonation	  time,	  sentences	  “Say,	  that’s	  
excellent,”	  and	  “No,	  he	  meant	  you,”	  SIT	  sentences,	  and	  a	  compilation	  of	  sound	  
samples	  to	  be	  used	  for	  CAPE-­‐V	  ratings.	  
Data	  Analysis:	  Intelligibility	  
Three	  different	  novel,	  inexperienced	  listeners	  transcribed	  each	  speaker’s	  
spontaneous	  sentences	  and	  sentences	  from	  the	  SIT,	  with	  no	  one	  listener	  hearing	  the	  
same	  sentence	  more	  than	  once.	  	  Each	  was	  limited	  to	  20	  minutes	  of	  listening	  and	  
transcription	  to	  reduce	  listener	  fatigue.	  	  Listeners	  used	  laptops	  to	  transcribe	  what	  
they	  heard	  as	  the	  sentences	  were	  played	  for	  them.	  	  Prior	  to	  playing	  each	  set	  of	  
sentences,	  amplification	  levels	  on	  the	  speakers	  were	  set	  to	  match	  the	  same	  sound	  
level	  meter	  values	  while	  playing	  back	  the	  calibration	  tones	  recorded	  during	  the	  
clinical	  session.	  Listeners	  were	  instructed	  that	  they	  would	  hear	  each	  sentence	  only	  
once	  and	  that	  they	  were	  to	  transcribe	  exactly	  what	  they	  heard,	  without	  regard	  for	  
punctuation	  or	  capitalization.	  	  They	  were	  told	  not	  to	  make	  any	  corrections	  until	  the	  
entire	  sentence	  was	  transcribed,	  to	  reduce	  their	  memory	  load.	  	  Pauses	  were	  given	  
until	  the	  listener	  was	  ready	  to	  start	  the	  next	  sentence	  and	  after	  each	  set	  of	  10	  
sentences.	  
Sentences	  were	  transcribed	  into	  Microsoft	  Excel	  spreadsheets	  and	  compared	  
with	  transcriptions	  made	  by	  the	  researchers,	  who	  had	  listened	  to	  the	  sentences	  in	  
context	  for	  an	  unlimited	  number	  of	  times	  and,	  when	  needed,	  at	  a	  higher	  intensity.	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Comparisons	  were	  made	  with	  R,	  Package	  ‘qualV’	  (60)	  using	  the	  Least	  
Common	  Sequence	  (LCS)	  function	  algorithm.	  	  Prior	  to	  running	  the	  program,	  the	  
entire	  spreadsheet	  was	  checked	  for	  spelling	  errors.	  	  The	  LCS	  algorithm	  was	  adapted	  
to	  do	  a	  number	  of	  things:	  text	  was	  converted	  to	  lowercase	  without	  punctuation,	  
single	  spaces	  between	  words	  and	  delete	  leading	  spaces,	  so	  as	  not	  to	  count	  these	  as	  
transcriber	  errors.	  	  The	  algorithm	  then	  created	  output	  columns	  that	  examined	  for	  
the	  least	  common	  sequence,	  or	  the	  number	  of	  identical	  words	  that	  were	  in	  the	  same	  
sequence	  as	  the	  key	  sentence.	  	  Then,	  the	  number	  of	  identical	  words	  in	  the	  sequence	  
was	  divided	  by	  the	  greatest	  number	  of	  words	  in	  either	  sentence,	  so	  that	  errors	  of	  
omission	  and	  commission	  were	  accounted	  for.	  	  The	  mean	  percent	  intelligibility	  of	  a	  
set	  of	  10	  sentences	  for	  each	  spontaneous	  task,	  and	  11	  for	  the	  SIT	  task	  was	  
determined	  and	  saved	  in	  the	  dataset	  as	  SIHOME	  (home	  percent	  speech	  intelligibility),	  
SICLINIC	  (clinic	  percent	  speech	  intelligibility)	  and	  SITR	  (SIT	  as	  calculated	  by	  R).	  
To	  determine	  the	  accuracy	  of	  the	  LCS	  algorithm,	  a	  random	  sample	  of	  10	  
spontaneous	  sentences	  from	  SIHOME	  and	  SICLINIC	  were	  calculated	  for	  intelligibility	  by	  
hand	  based	  on	  an	  early	  SIT	  protocol(61),	  then	  compared	  to	  the	  LCS	  code	  written	  for	  
R,	  resulting	  in	  a	  perfect	  correlation	  (R2=1.0)	  with	  0%	  disagreement.	  Comparisons	  
were	  also	  made	  between	  the	  R	  LCS	  output	  for	  SIT	  sentences	  (SITR)	  and	  the	  SIT	  
software	  output(41)	  for	  percent	  word	  intelligibility	  in	  sentences	  in	  a	  sample	  of	  44	  
transcribed	  SIT	  sentences,	  resulting	  in	  a	  very	  high	  correlation	  (R2=.98)	  with	  3.26%	  
disagreement.	  R	  LCS	  allowed	  for	  over	  3500	  lines	  of	  ineligibility	  to	  be	  analyzed	  in	  
moments,	  reducing	  bias	  and	  human	  error.	  	  
Data	  Analysis:	  Acoustic	  Measures	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All	  acoustic	  measurements	  (SPL,	  HNR,	  MPT,	  F0	  mean	  and	  standard	  deviation)	  
were	  analyzed	  using	  Praat	  (47)	  software	  for	  speech	  analysis	  version	  5.3.70.	  	  	  
Intensity	  of	  each	  spontaneous	  utterance	  was	  measured	  with	  Praat	  intensity	  
set	  to	  show	  a	  range	  of	  25dB	  to	  100dB	  with	  “subtract	  mean	  pressure”	  checked	  as	  OFF.	  
If	  pauses	  in	  the	  midst	  of	  an	  utterance	  were	  greater	  than	  150	  ms,	  they	  were	  deleted	  
(62)	  before	  the	  mean	  intensity	  was	  computed,	  from	  the	  beginning	  to	  the	  end	  of	  the	  
sound	  contour	  (Fig.	  2).	  	  The	  intensity	  level	  was	  converted	  into	  decibels	  in	  sound	  
pressure	  level	  re	  .0002	  dynes/cm2	  using	  the	  slope	  and	  y-­‐intercept	  of	  the	  linear	  
interpolation	  derived	  from	  measurement	  of	  calibration	  tones	  from	  the	  LENA-­‐DLP	  
used	  to	  record	  the	  sample.	  	  The	  mean	  dB-­‐SPL	  of	  each	  participant’s	  sentences	  in	  each	  
environment	  was	  calculated	  (SPLCLINIC	  and	  SPLHOME)	  by	  measuring	  the	  intensity	  of	  
each	  randomly	  selected	  utterance	  and	  calculating	  the	  average	  dB-­‐SPL	  of	  the	  10	  
utterances	  from	  the	  clinic	  and	  the	  average	  dB-­‐SPL	  of	  the	  10	  utterances	  from	  home.	  
Intensity	  of	  a	  sustained	  vowel	  was	  calculated	  in	  the	  same	  fashion.	  	  SPL	  
measure	  was	  taken	  from	  the	  middle	  90%	  of	  the	  sustained	  vowel	  /a/	  at	  comfortable	  
loudness	  and	  pitch,	  and	  the	  same	  settings	  and	  procedures	  as	  above	  (SPLVOWEL).	  	  
Harmonic	  to	  Noise	  Ratio	  (HNR)	  was	  also	  taken	  from	  this	  sustained	  vowel	  at	  
comfortable	  loudness	  and	  pitch.	  
Maximum	  Phonation	  Time	  (MPT)	  was	  measured	  from	  participants	  response	  
the	  script	  task	  “now	  I	  want	  you	  to	  say	  /a/	  and	  hold	  it	  for	  as	  long	  as	  you	  can.”	  	  The	  
voiced	  signal	  was	  visualized,	  the	  cursor	  was	  set	  at	  the	  beginning	  and	  the	  end	  of	  the	  
sound	  signal,	  and	  the	  time	  was	  noted	  and	  saved	  for	  the	  dataset.	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Frequency	  range	  was	  measured	  from	  participants’	  imitations	  of	  the	  auditory	  
models	  presented	  via	  digital	  recording	  for,	  “Say,	  that’s	  excellent,”	  and	  “No,	  he	  meant	  
you.”	  	  Praat	  was	  used	  to	  detect	  the	  mean	  fundamental	  frequency	  and	  standard	  
deviation	  from	  each	  sentence.	  and	  the	  interquartile	  range	  was	  calculated	  via	  the	  75th	  
percentile	  z-­‐score	  (0.674)	  to	  find	  the	  actual	  75th	  percentile	  of	  the	  distribution.	  	  Z-­‐
score	  0.674=(x75-­‐mean)/(SD),	  and	  solve	  for	  x75	  for	  the	  75th	  percentile.	  	  Then,	  
because	  of	  the	  symmetry	  of	  the	  standard	  normal	  distribution,	  the	  25th	  percentile	  is	  
calculated	  as	  the	  same	  distance	  from	  the	  mean	  as	  the	  75th	  percentile,	  but	  in	  the	  
opposite	  direction;	  x25=mean-­‐(x75-­‐mean).	  	  The	  difference	  between	  the	  25th	  and	  75th	  
(x75-­‐x25=IQR)	  percentile	  was	  saved	  for	  the	  dataset	  (F0-­‐IQR).	  	  	  
Data	  Analysis:	  Perceptual	  Measures	  
CAPE-­‐V	  ratings	  were	  performed	  by	  an	  expert	  voice	  clinician,	  who	  was	  given	  
sound	  samples	  for	  each	  participant	  (n=13),	  including	  distractor	  samples	  of	  healthy	  
controls	  (n=12).	  	  Each	  file	  was	  randomly	  numbered	  so	  that	  the	  identification	  of	  each	  
participant	  was	  masked	  and	  not	  identified	  as	  either	  PD	  or	  HV.	  Each	  digital	  recording	  
included:	  1-­‐2	  minutes	  of	  conversation	  between	  the	  experimenter	  and	  participant,	  
SIT	  sentences,	  and	  the	  script	  recording	  of	  speech	  tasks.	  	  The	  expert	  clinician	  listened	  
to	  the	  digital	  recordings	  and	  filled	  out	  a	  CAPE-­‐V	  rating	  form	  on	  each.	  	  The	  
experimenter	  then	  measured	  the	  overall	  rating	  and	  calculated	  the	  overall	  score	  for	  
each	  participant	  (out	  of	  100	  mm).	  
Statistical	  Methods	  
A	  power	  analysis	  was	  conducted	  based	  on	  Hellman,	  2012(63).	  Effect	  size	  
differences	  between	  the	  clinic	  and	  home	  measures	  ranged	  from	  0.38	  to	  1.47	  for	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intelligibility	  and	  from	  0.41	  to	  1.8	  for	  intensity	  in	  four	  participants.	  	  For	  a	  power	  of	  
0.80,	  11	  subjects	  were	  required	  to	  find	  differences	  on	  measures	  of	  speech	  
intelligibility	  at	  α=0.025	  while	  8	  subjects	  were	  required	  to	  find	  intensity	  differences	  
at	  α=0.025	  (Bonferroni	  corrected	  for	  2	  outcome	  variables)	  between	  clinic	  and	  home	  
environments.	  
Two-­‐way	  repeated	  measures	  ANOVA	  compared	  clinic	  versus	  natural	  
environment	  (environment)	  within	  subjects	  and	  PD	  versus	  healthy	  volunteers	  
(group)	  between	  subjects	  and	  the	  interaction	  of	  environment	  and	  group	  for	  each	  
dependent	  variable:	  speech	  intelligibility,	  and	  intensity.	  
Exploratory	  stepwise	  multiple	  regression	  analyses	  examined	  the	  predictor	  
variables	  SITR,	  CAPE-­‐V,	  SPLVOWEL,	  HNR,	  MPT	  and	  F0-­‐IQR	  against	  the	  outcome	  
variable	  SIHOME.	  	  Single	  regressions	  were	  also	  performed	  on	  each	  predictor	  variable.	  
Results	  
Participants	  	  
Thirteen	  participants	  with	  idiopathic	  Parkinson’s	  disease	  (7	  Men,	  6	  women,	  
55	  to	  74	  years,	  median	  70	  years)	  participated	  in	  the	  study.	  	  The	  12	  healthy	  
volunteers	  were	  over	  50	  (4	  Men,	  8	  women,	  53	  to	  70	  years,	  median	  60.5	  years).	  	  The	  
participant	  data	  are	  presented	  in	  Table	  1.	  	  All	  but	  one	  participant	  was	  on	  
medication	  for	  PD,	  the	  one	  who	  chose	  holistic	  treatments;	  all	  earned	  a	  minimum	  
score	  of	  23/30	  on	  the	  MMSE(56).	  The	  range	  of	  overall	  impairment	  at	  the	  time	  of	  
speech	  evaluation	  extended	  from	  mild	  to	  moderate	  severe	  disability.	  Three	  
participants	  had	  deep	  brain	  stimulators	  and	  settings	  remained	  constant	  during	  the	  
study.	  Of	  the	  13	  participants	  with	  PD,	  7	  reported	  no	  history	  of	  speech	  therapy,	  4	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reported	  Lee	  Silverman	  Speech	  Therapy	  (LSVT),	  or	  “4	  weeks	  of	  talking	  loud,”	  and	  2	  
reported	  other	  types	  of	  speech	  therapy.	  	  The	  most	  recent	  speech	  therapy	  was	  1.5	  
years	  prior	  to	  participation	  in	  the	  study.	  Two	  participants	  in	  the	  HV	  group	  were	  
spouses	  of	  volunteers	  in	  the	  PD	  group.	  	  Out	  of	  27	  volunteers,	  two	  did	  not	  participate:	  	  
One	  volunteer	  withdrew	  prior	  to	  participation	  as	  their	  primary	  communication	  
partner	  in	  the	  home	  opted	  not	  to	  participate;	  another	  did	  not	  have	  any	  speech	  or	  
voice	  difficulties.	  
Listeners	  
Fifty-­‐eight	  listeners	  participated	  in	  the	  study.	  	  Their	  ages	  ranged	  from	  18	  to	  
53	  years	  (mean	  21.9	  years).	  	  None	  had	  completed	  clinical	  experience	  or	  coursework	  
in	  motor	  speech	  disorders	  or	  voice	  at	  the	  time	  of	  their	  participation.	  All	  listeners	  
were	  native	  speakers	  of	  standard	  American	  English,	  free	  of	  neurological	  or	  
psychiatric	  disorders,	  had	  visual	  acuity	  adequate	  to	  perform	  the	  task,	  and	  passed	  a	  
hearing	  screening.	  	  Sixty	  volunteered,	  one	  was	  excluded	  due	  to	  not	  passing	  the	  
hearing	  screening,	  and	  another	  was	  excluded	  after	  self-­‐reporting	  an	  auditory	  
processing	  disorder.	  	  Most	  listeners	  did	  one	  session	  per	  day	  (n=53),	  and	  no	  more	  
than	  three	  sessions	  per	  day	  (n=3).	  
Inter-­‐rater	  reliability	  
All	  listeners’	  responses	  on	  3	  of	  the	  same	  samples	  were	  examined	  using	  
intraclass	  correlation	  coefficients.	  	  Intraclass	  correlations	  were	  0.946-­‐0.980,	  
exceeding	  our	  predetermined	  minimum	  standard	  of	  0.65.	  
Effect	  of	  Environment	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Statistical	  analyses	  were	  completed	  using	  SPSS	  professional	  statistics	  version	  
21(64).	  Two-­‐way	  repeated	  ANOVAs	  compared	  environment	  (clinical	  and	  home)	  
within	  subjects	  and	  between	  groups	  (PD	  vs.	  controls).	  	  	  
Significant	  effects	  of	  environment	  were	  found	  on	  intensity	  (F=12.563,	  p=.02).	  	  
No	  group	  difference	  was	  found	  (F=1.274,	  p=0.271)	  and	  no	  interaction	  between	  
intensity	  and	  group	  (F=.025,	  p=.86).	  	  	  Specifically,	  both	  groups	  had	  higher	  mean	  
intensity	  levels	  in	  the	  home	  environment	  than	  in	  the	  clinical	  environment	  (Fig.	  3).	  
Environmental	  effects	  within	  groups	  were	  significant;	  HV	  (F=7.624,	  p=0.019)	  and	  
PD	  (F=5.694,	  p=0.034).	  	  	  
Intelligibility	  scores	  did	  not	  differ	  between	  environments	  (F=.389,	  p=.539)	  
with	  no	  group	  by	  environment	  interaction	  (F=.048,	  p=.829).	  However,	  significant	  
group	  differences	  were	  found	  across	  both	  environments	  (F=14.988,	  p=0.001),	  and	  
in	  the	  clinic	  (F=13.552,	  p=0.001)	  and	  the	  home	  environment	  (F=10.055,	  p=0.004)	  
(Fig.	  4).	  	  	  
Correlation	  Coefficients	  Between	  Clinical	  Measures	  and	  Speech	  in	  the	  Home	  
Correlation	  coefficients	  examined	  relationships	  between	  speech	  intensity	  
and	  intelligibility	  in	  the	  clinic	  and	  the	  home	  environment.	  No	  significant	  
relationships	  (p≤0.05)	  were	  found	  between	  intensity	  and	  intelligibility	  within	  either	  
group	  in	  either	  environment.	  Within	  the	  PD	  group,	  a	  significant	  relationship	  was	  
found	  between	  spontaneous	  speech	  intelligibility	  in	  the	  clinical	  and	  the	  home	  
environments	  (R2=.309,	  p=.048).	  	  No	  significant	  relationships	  were	  found	  between	  
years	  since	  diagnosis	  and	  intensity	  in	  the	  home	  environment	  (R2=.297,	  p=.054);	  
between	  years	  since	  diagnosis	  and	  intelligibility	  in	  the	  home	  environment	  (R2=.259,	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p=.076);	  between	  speech	  intensity	  in	  the	  home	  environment	  and	  the	  depression	  
index	  (R2=.125,	  p=.236)	  or	  between	  intelligibility	  in	  the	  home	  environment	  and	  
depression	  (R2=.118,	  p=.250).	  	  The	  average	  background	  noise	  within	  50	  ms	  of	  target	  
sentences	  in	  the	  home	  environment	  and	  average	  sentence	  dB-­‐SPL	  shared	  a	  weak,	  
non-­‐significant,	  positive	  correlation	  (R2=0.289,	  p=0.058)	  across	  participants.	  	  	  
Exploring	  Predictions	  Between	  Clinical	  Measures	  and	  Speech	  in	  the	  Home	  
To	  explore	  the	  relationship	  between	  percent	  speech	  intelligibility	  in	  the	  
home	  and	  measures	  of	  speech	  in	  the	  clinic	  in	  a	  person	  with	  PD	  (Table	  2),	  we	  
performed	  a	  stepwise	  multiple	  regression.	  The	  combination	  with	  the	  highest	  
predictive	  value	  was	  SPLVOWEL	  and	  SITR	  in	  relationship	  with	  SIHOME	  F(2,10)=12.755,	  
p=.002.	  	  The	  multiple	  correlations	  coefficient	  for	  SITR+SPLVOWEL	  R2=.662,	  indicating	  
that	  approximately	  66.2%	  of	  the	  variance	  of	  SIHOME	  could	  be	  accounted	  for	  by	  
SITR+SPLVOWEL.	  	  From	  this	  data,	  the	  prediction	  equation	  can	  be	  constructed	  as:	  	  
Predicted	  SIHOME	  =	  83.901+1.683(SITR)-­‐1.922(SPLVOWEL)	  
This	  indicated	  that	  the	  SITR	  score	  was	  adjusted	  downward	  by	  SPLVOWEL	  to	  best	  
predict	  SIHOME.	  
	   Single	  regressions	  of	  each	  predictor	  variable	  against	  the	  outcome	  variable,	  
SIHOME,	  while	  correcting	  alpha	  for	  6	  variables	  (p<.008333),	  revealed	  that	  only	  SITR	  
F(1,11)=10.546,	  p=.008	  had	  a	  significant	  prediction	  of	  SIHOME	  (R2=0.489,	  p=.004)	  
(Fig.5).	  	  No	  other	  variable	  had	  predictability	  alone.	  	  
Discussion	  
This	  study	  compared	  intensity	  and	  intelligibility	  between	  the	  clinical	  and	  
home	  environments	  in	  PD	  and	  healthy	  volunteers.	  Our	  expectation	  was	  that	  within	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the	  clinic,	  the	  contextual	  emphasis	  on	  speech	  might	  focus	  the	  participants	  more	  on	  
how	  they	  are	  speaking,	  while	  at	  home,	  participants	  would	  be	  more	  distracted	  and	  
focus	  on	  what	  they	  are	  going	  to	  say	  and	  not	  how	  they	  are	  speaking,	  thereby	  reducing	  
intelligibility	  and	  intensity.	  	  	  We	  also	  expected	  patients	  would	  be	  distracted	  from	  
communication	  by	  concurrent	  tasks	  (32,65)	  in	  the	  home	  that	  were	  not	  present	  in	  
the	  clinic.	  By	  using	  the	  same	  device	  and	  conversational	  speech	  in	  both	  settings,	  we	  
sought	  to	  minimize	  testing	  effects.	  
	   Statistical	  analysis	  of	  intelligibility	  and	  intensity	  within	  the	  clinical	  and	  home	  
environments	  showed	  different	  effects	  from	  those	  expected.	  Both	  groups	  had	  higher	  
speech	  intensity	  in	  the	  home	  environment.	  	  Individuals’	  speech	  intensity	  did	  not	  
correlate	  with	  their	  intelligibility	  scores	  and	  no	  environmental	  effects	  were	  found	  in	  
speech	  intelligibility.	  	  The	  results	  of	  the	  current	  study	  show	  differences	  between	  
environments	  only	  in	  speech	  intensity.	  	  As	  this	  did	  not	  relate	  to	  background	  noise,	  
the	  increased	  intensity	  in	  the	  home	  environment	  is	  likely	  due	  to	  other	  factors,	  such	  
as	  motivation	  and	  proximity	  to	  communication	  partner.	  
	   Although	  it	  is	  common	  clinical	  practice	  is	  to	  address	  intensity	  in	  speech	  
therapy	  for	  PD	  and	  hypophonia	  is	  an	  agreed-­‐upon	  marker	  of	  the	  disease	  (66),	  we	  
found	  that	  speech	  intensity	  did	  not	  differ	  between	  healthy	  volunteers	  and	  
participants	  with	  PD.	  	  Persons	  with	  PD	  had	  lower	  intelligibility	  scores	  than	  the	  HV	  in	  
both	  environments	  but	  did	  not	  differ	  in	  intensity	  from	  HV	  in	  either	  environment.	  	  
Previous	  research	  has	  focused	  on	  clinical	  outcomes	  of	  therapy	  for	  voice/speech	  
problems	  in	  PD,	  focusing	  on	  intensity	  measures	  such	  as	  dB-­‐SPL	  on	  a	  sustained	  
vowel	  (19).	  	  This	  study	  demonstrates	  that	  an	  increased	  focus	  on	  intelligibility	  as	  a	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measure	  of	  speech	  impairment	  in	  PD	  is	  warranted.	  	  However,	  it	  should	  be	  noted	  that	  
this	  was	  an	  exploratory	  study	  based	  on	  natural	  speech	  intensity	  and	  intelligibility.	  	  
The	  participants	  were	  not	  given	  any	  instruction	  to	  increase	  their	  loudness	  or	  effort	  
during	  the	  time	  of	  this	  investigation.	  	  As	  there	  was	  no	  manipulation	  of	  speech	  
intensity	  in	  this	  study,	  no	  conclusions	  can	  be	  made	  whether	  intensity	  enhancement	  
might	  alter	  speech	  intelligibility	  in	  the	  home	  environment.	  	  	  
	   Previous	  authors	  had	  suggested	  that	  the	  communication	  partners	  of	  PD	  
patients	  report	  speech	  intelligibility	  at	  home	  was	  more	  problematic	  than	  in	  the	  
clinic	  (25-­‐27).	  Historically,	  clinicians	  and	  researchers	  have	  observed	  differences	  in	  
the	  clinic	  versus	  the	  natural	  environments	  (29,30,33)	  suggesting	  that	  cognitive	  load	  
and	  testing	  effects	  may	  lead	  to	  differences	  between	  “performance”	  speech	  and	  
“functional”	  speech.	  	  Our	  data	  did	  not	  support	  these	  clinical	  impressions.	  	  
Performance	  effects	  have	  also	  been	  discussed	  as	  possible	  enhancers	  of	  speech	  in	  the	  
clinical	  environment	  (67),	  that	  is	  a	  speech-­‐language	  pathologist	  may	  encourage	  
participants	  to	  have	  clearer	  and/or	  louder	  speech.	  However,	  results	  of	  this	  study	  
indicate	  that	  people	  with	  PD	  had	  greater	  speech	  intensity	  in	  their	  home	  
environment	  but	  no	  difference	  in	  intelligibility.	  	  This	  indicates	  that	  intensity	  of	  
spontaneous	  speech	  is	  affected	  by	  environment,	  in	  patients	  with	  PD	  but	  did	  not	  
differ	  from	  HV.	  	  Spontaneous	  speech	  intelligibility	  was	  not	  affected	  by	  environment,	  
but	  was	  affected	  by	  PD	  in	  comparison	  with	  HV.	  	  This	  suggests	  that	  intelligibility	  of	  
spontaneous	  speech	  may	  more	  reflective	  of	  the	  effect	  of	  PD	  on	  speech	  
communication	  (26).	  	  As	  the	  intensity	  of	  spontaneous	  speech	  did	  not	  differ	  between	  
PD	  and	  HV,	  it	  is	  less	  likely	  to	  be	  a	  measure	  of	  PD	  effects	  on	  speech.	  	  When	  
RUNNING	  HEAD:	  SPEECH	  FUNCTION	  IN	  PD;	  ENVIRONMENT,	  TASK,	  TREATMENT	  
	  
85	  
considering	  measures	  of	  speech	  impairment	  in	  PD,	  spontaneous	  speech	  
intelligibility	  should	  hold	  a	  primary	  position	  in	  clinical	  measures,	  as	  it	  reflected	  
speech	  intelligibility	  in	  the	  home.	  	  New	  methods	  of	  effective	  and	  efficient	  
measurement	  of	  intelligibility	  that	  can	  be	  used	  in	  both	  environments	  are	  needed.
	   To	  explore	  the	  relationship	  between	  the	  environments	  in	  the	  PD	  sample,	  we	  
examined	  predictability	  of	  clinical	  measures	  used	  in	  speech	  and	  voice	  clinical	  
evaluations	  with	  the	  speech	  intelligibility	  of	  the	  same	  participants	  in	  their	  home	  
environments.	  Two	  variables	  that	  best	  fit	  a	  prediction	  model	  for	  SIHOME	  were	  
combined	  SITR	  and	  SPLVOWEL.	  	  These	  findings	  suggest	  that	  clinical	  speech	  tasks	  that	  
do	  not	  require	  connected	  speech	  (such	  as	  sustained	  vowels	  for	  intensity,	  harmonic	  
to	  noise	  ratio,	  and	  maximum	  phonation	  time)	  were	  not	  predictive	  of	  intelligibility	  in	  
the	  home.	  	  This	  is	  contrary	  to	  previous	  research	  indicating	  that	  intensity,	  maximum	  
phonation	  time	  and	  frequency	  range	  are	  associated	  with	  clinical	  intelligibility	  
(44,48).	  	  However,	  other	  findings	  are	  in	  agreement	  with	  more	  current	  research	  
indicating	  that	  intensity	  interquartile	  range	  was	  not	  significantly	  predictive	  of	  
clinical	  intelligibility	  scores	  (53).	  	  	  
Our	  results	  showed	  that	  sentence	  intelligibility	  in	  a	  reading	  task	  (SITR)	  
corrected	  by	  intensity	  of	  a	  sustained	  vowel	  (SPLVOWEL)	  best	  predicted	  SIHOME.	  	  
Perhaps	  task	  must	  be	  considered	  when	  attempting	  to	  draw	  connections	  between	  
clinical	  tasks	  and	  functional	  speech	  tasks	  in	  the	  clinic.	  	  The	  SITR	  score	  derived	  from	  a	  
reading	  task	  was	  not	  related	  to	  spontaneous	  speech	  intelligibility	  in	  the	  clinic.	  	  
Further,	  SPLVOWEL	  was	  not	  related	  to	  intelligibility	  in	  either	  environment.	  	  Perhaps	  
voice	  and	  speech	  tasks	  that	  do	  not	  call	  on	  the	  patient	  with	  PD	  to	  use	  connected	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speech,	  such	  as	  isolated	  vowel	  tasks,	  may	  not	  be	  good	  indicators	  of	  speech	  
impairment	  in	  PD.	  	  It	  has	  been	  indicated	  that	  learning	  and	  behavioral	  effects	  may	  
blur	  these	  tasks	  over	  time(68).	  
	   Although	  the	  model	  of	  SITR+SPLVOWEL	  was	  statistically	  significant,	  accounting	  
for	  66.2%	  of	  the	  variance	  in	  SIHOME,	  33.8%	  remains	  unaccounted	  for	  and	  with	  the	  
significant	  individual	  predictor,	  the	  SITR,	  there	  was	  still	  51.1%	  of	  the	  variance	  in	  
SIHOME	  left	  unaccounted	  for.	  	  	  Thus,	  clinical	  tests	  used	  here	  could	  not	  substitute	  for	  
measuring	  speech	  intelligibility	  in	  the	  home	  environment.	  	  Further	  research	  is	  
warranted	  on	  clinical	  protocols	  and	  tasks	  that	  may	  relate	  to	  spontaneous	  speech	  in	  
patients’	  functional	  environments.	  	  Kim,	  Kent,	  and	  Weismer	  (53)	  reported	  that	  when	  
acoustic	  measures	  are	  regressed	  against	  scaled	  intelligibility	  scores	  (mild,	  moderate,	  
severe)	  on	  a	  reading	  task,	  in	  several	  disease	  groups	  (PD,	  Stroke,	  Traumatic	  Brain	  
Injury,	  Multiple	  Systems	  Atrophy)	  that	  some	  measures	  had	  predictive	  power	  to	  
intelligibility,	  including	  articulation	  rate	  (R2=.56),	  and	  F2	  slope	  (R2=.51	  for	  males,	  
R2=.46	  for	  females).	  	  The	  PD	  group	  in	  the	  Kim	  et.	  al	  study	  had	  the	  higher	  
intelligibility	  ratings,	  and	  therefore	  may	  have	  different	  results	  as	  a	  group.	  Currently,	  
reading	  intelligibility	  is	  used	  to	  rate	  intelligibility	  in	  the	  clinic.	  	  As	  discussed,	  the	  SITR	  
score	  does	  not	  seem	  to	  be	  closely	  related	  to	  SICLINIC	  (R2=.21),	  but	  SITR	  was	  related	  to	  
SIHOME	  (R2=.49).	  
	   Our	  results	  suggest	  that	  clinical	  measures	  of	  voice	  and	  speech	  may	  only	  
partially	  indicate	  the	  speech	  communication	  abilities	  of	  patients	  with	  PD	  in	  the	  
home.	  	  The	  SIT	  and	  measures	  of	  SPL	  in	  combination	  can	  lend	  some	  insight	  into	  the	  
speech	  behavior	  of	  the	  patient	  at	  home.	  	  The	  SITR	  was	  the	  only	  measure	  to	  indicate	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spontaneous	  speech	  intelligibility	  in	  the	  home.	  	  This	  exploratory	  study	  warrants	  
further	  exploration	  in	  a	  larger,	  more	  diverse	  (with	  regard	  to	  impairment),	  group	  of	  
patients.	  
	   Limitations	  of	  this	  study	  include	  a	  relatively	  small	  sample	  size,	  and	  that	  the	  
majority	  of	  participants	  with	  PD	  were	  only	  mildly	  to	  moderately	  affected.	  	  Also,	  the	  
use	  of	  clinical	  measures	  in	  common	  practice	  may	  not	  be	  as	  tightly	  controlled	  as	  our	  
measures	  were	  in	  this	  study.	  For	  example,	  our	  measure	  SITR,	  was	  well	  controlled	  
with	  regard	  to	  calibration,	  listener	  experience,	  and	  processing	  the	  data	  through	  R	  
LCS.	  	  This	  alternative	  to	  the	  commercially	  available	  version	  gave	  us	  a	  higher	  level	  of	  
control.	  	  We	  were	  able	  to	  demonstrate	  a	  very	  high	  level	  of	  correlation	  to	  the	  
commercially	  available	  SIT	  computer	  scoring	  program	  (R2=.98,	  err.=3.26%)	  
although	  some	  score	  differences	  may	  occur.	  
	   Further	  exploration	  is	  needed	  into	  contributions	  of	  background	  noise,	  
motivation,	  distance	  from	  conversational	  partners,	  and	  other	  cues	  from	  
conversational	  partners.	  	  For	  our	  study,	  we	  examined	  the	  relationship	  between	  the	  
mean	  environmental	  noise	  of	  all	  subjects	  in	  home	  and	  clinical	  environments,	  with	  
the	  mean	  speech	  intensities	  in	  each	  environment	  and	  did	  not	  find	  a	  significant	  
relationship.	  	  Comparing	  within-­‐subjects	  possible	  changes	  in	  sentence	  intensity	  in	  
response	  to	  changes	  in	  immediate	  background	  noise	  may	  show	  different	  results.	  	  
Motivation	  to	  be	  understood	  by	  functional	  communication	  partners	  in	  the	  home	  
may	  contribute	  positively	  to	  spontaneous	  speech	  intensity	  in	  the	  home	  environment.	  	  
In	  our	  experiment,	  conversational	  proximity	  was	  held	  constant	  in	  the	  clinical	  
environment,	  but	  could	  not	  be	  held	  constant	  in	  the	  home	  environment,	  and	  could	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have	  contributed	  to	  greater	  intensity	  at	  times	  in	  the	  home.	  	  Also,	  other	  cues	  from	  
conversational	  partners,	  such	  as	  asking	  for	  clarification,	  off	  topic	  responses,	  or	  even	  
lack	  of	  response,	  were	  not	  measured	  in	  this	  study.	  	  
	   This	  study	  emphasized	  the	  importance	  of	  the	  home	  environment	  in	  which	  
patients	  have	  most	  of	  their	  communication	  and	  where	  their	  communication	  is	  
important	  to	  quality	  of	  life.	  	  Clinical	  tasks	  cannot	  approximate	  the	  differing	  cognitive	  
loads	  and	  competition	  for	  resources	  in	  the	  home	  environment.	  New	  technologies	  are	  
making	  this	  type	  of	  measurement	  increasingly	  possible.	  	  Hardware	  is	  getting	  smaller	  
and	  more	  discreet,	  and	  software	  is	  becoming	  more	  powerful	  and	  portable.	  	  In	  this	  
study	  we	  utilized	  the	  LENA-­‐DLP,	  a	  simple	  encrypted	  digital	  recorder.	  	  Other	  
hardware	  options	  that	  are	  available	  are	  voice	  dosimeters,	  accelerometers	  (69)	  and	  
the	  combinations	  of	  accelerometers	  and	  acoustic	  transducers	  (70).	  Software	  for	  
voice	  analysis	  can	  be	  loaded	  on	  smartphones	  (71),	  and	  speech	  transcription	  
software	  may	  be	  applied	  to	  intelligibility.	  	  In	  the	  future,	  ambulatory	  monitoring	  of	  
speech	  and	  voice	  is	  expected	  to	  become	  more	  efficient	  and	  effective.	  
	   Clinically,	  this	  study	  suggests	  that	  spontaneous	  speech	  intelligibility	  is	  a	  
major	  factor	  affected	  in	  PD,	  and	  not	  spontaneous	  speech	  intensity.	  	  We	  found	  that	  
participants	  who	  were	  louder,	  even	  in	  spontaneous	  speech,	  did	  not	  necessarily	  have	  
greater	  speech	  intelligibility.	  	  This	  study	  examined	  several	  factors	  that	  may	  be	  
related	  to	  spontaneous	  speech	  intelligibility	  for	  communication	  at	  home.	  Even	  
among	  the	  strongest	  relationship	  of	  SITR	  (R2=.49)	  to	  SIHOME,	  this	  did	  not	  explain	  
more	  than	  half	  of	  the	  variance.	  	  Therefore,	  future	  research	  and	  development	  should	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include	  efficient	  and	  effective	  methods	  of	  measurement	  of	  intelligibility	  in	  the	  home	  
environment.	  
Clinical	  Messages	  
• Spontaneous	  speech	  intelligibility	  deficits	  in	  the	  clinical	  and	  home	  
environments	  are	  related.	  
• Perceived	  environmental	  effects	  from	  communication	  partners	  and	  
professionals	  must	  be	  corroborated	  by	  quantitative	  measures.	  
• Spontaneous	  speech	  intensity	  in	  mild	  to	  moderately	  severe	  PD	  may	  not	  differ	  
from	  healthy	  volunteers,	  while	  intelligibility	  is	  impaired	  in	  PD	  regardless	  of	  
environment.	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Table	  1:	  Participant	  Clinical	  Data	  









Diagnosis	   MMSE	  
	  Clinical	  Data	  of	  Participants	  with	  Parkinson's	  Disease	  
301	   72	   F	   50	   19	   10	   27	  
302	   74	   M	   40	   3	   10	   28	  
303	   71	   M	   67	   16.5	   4	   29	  
304	   55	   F	   59	   9	   2.5	   30	  
305	   71	   M	   42	   3	   6	   28	  
306	   70	   M	   37	   0	   13	   29	  
307	   63	   F	   52	   0	   10	   27	  
308	   65	   M	   60	   17	   15	   30	  
309	   57	   M	   8	   9	   2	   29	  
310	   70	   M	   65	   2	   3.5	   27	  
311	   73	   M	   18	   2	   2	   29	  
312	   55	   F	   50	   10	   5	   29	  
313	   74	   M	   48	   30	   6	   30	  
Clinical	  Data	  of	  Healthy	  Volunteers	  
401	   56	   F	   3	   .	   .	   30	  
402	   59	   F	   9	   14	   .	   30	  
403	   53	   M	   2	   1	   .	   30	  
404	   55	   F	   11	   .	   .	   29	  
405	   62	   M	   3	   6	   .	   30	  
406	   57	   F	   7	   0	   .	   29	  
407	   70	   F	   4	   3	   .	   25	  
408	   63	   F	   0	   0	   .	   30	  
409	   69	   M	   9	   0	   .	   30	  
410	   65	   M	   16	   2	   .	   29	  
411	   63	   F	   0	   4	   .	   29	  
412	   56	   F	   1	   0	   .	   28	  
	  
	   	  




Table	  2:	  Examination	  of	  Means	  (n=13)	  for	  patients	  with	  PD	  
	  	   Mean	  
Standard	  
Deviation	  
Home	  Percent	  Sentence	  Intelligibility	  (SIHOME)	   72.46	   17.30	  
Consensus	  Auditory	  Perceptual	  Evaluation	  of	  Voice	  (CAPE-­‐V)	   25.23	   12.51	  
Sentence	  Intelligibility	  Test	  (SITR)	   86.23	   9.88	  
Max	  Phonation	  Time	  (MPT)	   10.76	   3.41	  
Harmonic	  to	  Noise	  Ratio	  (HNR)	   18.53	   4.72	  
Fundamental	  Frequency	  Interquartile	  Range	  (F0-­‐IQR)	   43.63	   19.39	  
Sound	  Pressure	  Level	  in	  dB-­‐SPL	  (SPLVOWEL)	   81.43	   4.91	  
	  
	   	  




Figure	  1:	  LENA-­‐DLP.	  	  The	  DLP	  is	  2.5oz,	  measures	  approximately	  8cm	  x	  5cm	  x	  1cm.	  	  
Shown	  here	  is	  the	  money	  clip	  holder,	  used	  to	  hold	  the	  DLP	  and	  worn	  on	  model	  that	  is	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Figure	  2:	  Data	  Processing	  for	  Intensity.	  	  Demonstration	  of	  processing	  the	  utterance,	  
“More	  or	  less	  keeping	  my	  brain	  a	  little	  more	  active,”	  intensity	  reading	  in	  Praat,	  with	  
pause	  (selected	  0.5485	  seconds	  in	  top	  image)	  and	  with	  pause	  removed	  (bottom).	  
Bottom	  image	  shows	  selection	  of	  utterance	  (length	  indicated	  as	  2.33	  seconds)	  and	  
deselection	  of	  noise	  before/after	  target	  utterance.	  	  Once	  the	  utterance	  is	  selected,	  
mean	  intensity	  appears	  alongside	  the	  spectrograph,	  or	  can	  be	  selected	  through	  
dropdown	  menus.	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Figure	  3:	  Examination	  of	  Intensity	  Between	  Groups.	  Showing	  intensity	  within	  
environments	  clinic	  and	  home	  for	  healthy	  controls	  (top)	  and	  PD	  (bottom).	  Significant	  
effects	  of	  environment	  (F=12.563,	  p=.02).	  	  No	  group	  difference	  (F=1.274,	  p=0.271)	  and	  
no	  interaction	  between	  intensity	  and	  group	  (F=.025,	  p=.86).	  	  	  Specifically,	  both	  groups	  
had	  higher	  mean	  levels	  of	  intensity	  in	  the	  home	  environment	  than	  in	  the	  clinical	  
environment.	  Environmental	  effects	  were	  found	  within	  groups,	  HV	  (F=7.624,	  p=0.019)	  
and	  PD	  (F=5.694,	  p=0.034).	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Figure	  4:	  Spontaneous	  Speech	  Percent	  Intelligibility	  by	  Environment	  and	  Group.	  
Boxes	  represent	  1st	  and	  2nd	  quartiles	  and	  median.	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Figure	  5:	  Regression	  of	  Sentence	  Intelligibility	  Test	  on	  Percent	  Sentence	  




y	  =	  1.2248x	  -­‐	  33.152	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  Intelligibility	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  (SIT)	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  Predictor	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  Study:	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The	  Effect	  of	  Use	  of	  SpeechVive™	  on	  Unaided	  Intelligibility	  and	  Intensity	  in	  the	  
Home	  Environment	  in	  Parkinson’s	  Disease:	  A	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  Study	  
Carrie	  E.	  Rountrey,	  Nina	  M.	  Borras,	  Jessica	  E.	  Huber,	  Christy	  L.	  Ludlow	  
James	  Madison	  University	  
Department	  of	  Communication	  Sciences	  and	  Disorders	  
	   	  




Purpose:	  	  To	  assess	  pre-­‐	  and	  post-­‐	  treatment	  measures	  of	  speech	  intelligibility	  and	  
intensity,	  when	  unaided,	  within	  the	  natural	  environment,	  before	  and	  after	  12	  weeks	  
of	  treatment	  with	  the	  SpeechVive™	  wearable	  device.	  
Methods:	  Seven	  patients	  with	  PD	  were	  recorded	  in	  their	  homes	  with	  the	  LENA-­‐DLP	  
wearable	  device	  when	  not	  using	  the	  SpeechVive™	  device.	  	  Spontaneous	  sentences	  
were	  randomly	  chosen	  for	  analysis.	  	  Three	  different	  listeners	  judged	  sentence	  
intelligibility.	  Intensity	  of	  spontaneous	  sentences	  was	  interpolated	  via	  calibration	  of	  
devices	  with	  a	  sound	  pressure	  meter.	  	  	  
Results:	  Repeated	  measures	  ANOVAs	  determined	  that	  before	  and	  after	  application	  
of	  SpeechVive™	  device	  for	  12	  weeks,	  there	  was	  no	  significant	  difference	  in	  
intelligibility	  (F(1,6)=.071,	  p=.798)	  or	  intensity	  (F(1,6)=.021,	  p=.890).	  	  The	  effect	  
sizes	  of	  Cohen’s	  d	  were	  0.055	  and	  0.15	  respectively.	  	  Given	  the	  very	  small	  effect	  
sizes,	  these	  pilot	  data	  suggest	  that	  the	  effects	  on	  unaided	  speech	  are	  negligible	  after	  
using	  the	  device	  for	  12	  weeks.	  
Conclusions:	  	  Application	  of	  the	  SpeechVive™	  device	  for	  12	  weeks	  did	  not	  elicit	  a	  
statistically	  significant	  difference	  in	  spontaneous	  speech	  intelligibility	  or	  intensity	  in	  
the	  home,	  when	  not	  wearing	  the	  aid.	  	  Further	  investigation	  with	  a	  larger	  sample	  size	  
is	  not	  warranted.	  	  However,	  the	  sample	  included	  only	  mild	  to	  moderately	  affected	  
patients	  who	  may	  be	  less	  susceptible	  to	  treatment	  effect.	   	  




In	  recent	  years,	  many	  persons	  with	  PD	  who	  seek	  treatment	  for	  hypophonia	  
and	  reduced	  intelligibility	  do	  so	  through	  Lee	  Silverman	  Voice	  Treatment	  (LSVT),	  but	  
not	  all	  patients	  have	  demonstrated	  progress	  using	  LSVT.	  	  Generalization	  of	  skills	  to	  
the	  natural	  environment	  has	  not	  been	  demonstrated,	  and	  this	  may	  be	  due	  to	  sensory	  
and	  cognitive	  problems	  in	  persons	  with	  PD	  (Countryman	  &	  Ramig,	  1993;	  Fox	  et	  al.,	  
2002).	  	  LSVT	  requires	  4	  days/week	  for	  4	  weeks	  of	  intensive	  therapy	  and	  compliance	  
with	  homework	  to	  be	  successful,	  and	  also	  requires	  the	  person	  with	  PD	  to	  remember	  
to	  “think	  loud,”	  when	  s/he	  is	  in	  functional	  communication	  situations.	  	  Many	  of	  the	  
participants	  in	  LSVT’s	  published	  clinical	  trials	  are	  persons	  with	  PD	  who	  have	  mild	  to	  
moderate	  dysarthria	  and	  relatively	  in	  tact	  cognition	  (Ramig	  et	  al.,	  1995;	  Ramig	  &	  
Dromey,	  1996).	  
The	  effects	  of	  external	  cues	  on	  limb	  movement	  and	  voice	  in	  persons	  with	  PD	  
may	  indicate	  that	  people	  with	  PD	  might	  benefit	  from	  targets	  for	  motor	  movements,	  
both	  gross	  (limb)	  and	  fine	  (speech/voice).	  	  Such	  cues	  have	  resulted	  in	  improvement	  
in	  handwriting,	  gait	  and	  voice	  loudness	  (Ho	  et	  al.,	  1999;	  Ho	  et	  al.,	  1999;	  Morris	  et	  al.,	  
1994;	  Oliveira	  et	  al.,	  1997;	  Sadagopan	  &	  Huber,	  2007).	  
To	  alleviate	  possible	  difficulties	  with	  self	  cuing	  apparent	  in	  PD,	  and	  to	  
provide	  a	  naturalistic	  external	  cue,	  Huber	  and	  colleagues	  have	  developed	  the	  
SpeechVive™,	  a	  wearable	  device	  for	  persons	  with	  PD.	  	  The	  device	  fits	  on	  the	  ear	  like	  
a	  behind-­‐the-­‐ear	  hearing	  aid	  (Fig.1)	  and	  delivers	  “babble,”	  to	  elicit	  the	  Lombard	  
effect	  when	  the	  patient	  speaks.	  	  The	  device	  senses	  the	  patient’s	  vocalization	  through	  
an	  accelerometer	  and	  only	  delivers	  background	  “babble”	  when	  the	  patient	  is	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speaking.	  	  Sadagopan	  and	  Huber	  (2007)	  have	  shown	  similar	  responses	  to	  multi-­‐
talker	  babble	  in	  persons	  with	  PD	  and	  healthy	  controls.	  	  Both	  groups	  increased	  their	  
sound	  pressure	  level	  and	  respiratory	  kinematics	  resulting	  in	  increases	  in	  intensity	  
and	  efficiency	  of	  respiratory	  patterns	  with	  multi-­‐talker	  babble.	  	  As	  the	  SpeechVive™	  
device	  can	  be	  used	  in	  the	  home,	  it	  can	  become	  a	  part	  of	  the	  patient’s	  activities	  of	  
daily	  living,	  which	  should	  improve	  generalization	  of	  skills	  and	  heighten	  the	  
probability	  of	  realizing	  gains	  in	  communication	  at	  home.	  	  
Principles	  of	  practice	  and	  exercise	  physiology	  indicate	  that	  heavier	  loading	  
on	  the	  muscles	  results	  in	  increased	  strength	  (Taaffe	  et	  al.,	  1999).	  	  As	  patients	  speak	  
more	  loudly,	  they	  may	  be	  increasing	  strength	  in	  the	  respiratory	  muscles	  thus	  the	  
SpeechVive™	  may	  increase	  speech	  intensity	  after	  12	  weeks	  of	  speaking	  with	  the	  
device.	  If	  speech	  intensity	  increases	  with	  device	  use,	  then	  speech	  intelligibility	  may	  
increase	  as	  well	  (Forrest	  et	  al.,	  1989).	  	  Therefore	  we	  hypothesized	  that	  intelligibility	  
in	  connected	  speech	  would	  increase	  after	  12	  weeks	  of	  device	  use.	  	  We	  measured	  this	  
using	  the	  LENA	  digital	  encrypted	  recording	  device	  (Ford	  et	  al.,	  2008)	  in	  the	  home	  
environments	  of	  the	  participants,	  without	  the	  device	  on	  to	  determine	  if	  there	  is	  
carryover	  in	  the	  patients’	  functional	  environment.	  	  	  
Methods	  
Participants	  
All	  of	  the	  participants	  also	  participated	  in	  Rountrey	  et	  al.,	  in	  preparation.	  	  
Participants	  were	  recruited	  through	  word-­‐of-­‐mouth,	  flyers,	  local	  PD	  support	  groups,	  
and	  Sentara	  Rockingham	  Memorial	  Hospital	  Voice	  and	  Swallowing	  Services.	  A	  
phone	  screening	  was	  used	  to	  determine	  inclusion	  in	  the	  study.	  	  Informed	  consent	  
RUNNING	  HEAD:	  SPEECH	  FUNCTION	  IN	  PD;	  ENVIRONMENT,	  TASK,	  TREATMENT	  
	  
107	  
was	  sent	  to	  all	  included	  participants	  ahead	  of	  time	  for	  informational	  purposes,	  and	  
was	  reviewed	  and	  signed	  at	  the	  time	  of	  their	  appointment.	  	  James	  Madison	  
University’s	  Institutional	  Review	  Board	  (IRB)	  and	  Sentara	  Rockingham	  Memorial	  
Hospital’s	  IRB	  approved	  the	  protocol	  for	  this	  study,	  including	  informed	  consent	  and	  
all	  recruitment	  materials.	  
Our	  inclusion	  criteria	  dictated	  that	  our	  participants	  with	  PD	  must	  have	  a	  
diagnosis	  from	  a	  neurologist	  of	  PD,	  and	  must	  be	  50	  years	  of	  age	  or	  older.	  	  They	  were	  
to	  earn	  a	  score	  of	  23	  or	  higher	  on	  the	  Folstein	  Mini	  Mental	  State	  Examination	  
(MMSE)	  (Folstein	  et	  al.,	  1975),	  and	  pass	  an	  audiological	  screening	  at	  40	  dB-­‐HL	  at	  
500,	  1000,	  2000,	  3000	  and	  4000	  Hz	  (allowing	  for	  4000	  Hz	  notch	  in	  one	  ear,	  
especially	  if	  the	  participant	  had	  experience	  with	  firearms).	  	  The	  participants’	  
speech/voice	  impairment	  had	  to	  be	  typical	  of	  hypophonia	  and/or	  dysarthria	  
commensurate	  with	  PD	  as	  judged	  by	  a	  practicing	  speech-­‐language	  pathologist	  with	  
experience	  in	  neurological	  disorders.	  Exclusion	  critera	  for	  the	  study	  included:	  
history	  of	  voice	  or	  speech	  problems	  prior	  to	  PD	  diagnosis,	  diagnosis	  of	  neurological	  
disease(s)	  other	  than	  PD,	  current	  diagnosis	  of	  mental	  illness	  except	  depression,	  and	  
non-­‐native	  Standard	  American	  English	  speaker.	  	  	  	  
Participants	  were	  encouraged	  to	  make	  their	  initial	  appointments	  at	  a	  time	  of	  
day	  that	  was	  best	  for	  them,	  given	  their	  experience	  with	  their	  medication	  schedule.	  
Participants	  tended	  to	  choose	  mid-­‐	  to	  late-­‐	  morning	  appointments,	  usually	  within	  1-­‐
2	  hours	  after	  medication.	  	  No	  participants	  exhibited	  dyskinesias	  at	  the	  time	  of	  initial	  
testing,	  although	  dyskinesias	  during	  the	  home	  environment	  recordings	  can	  not	  be	  
ruled	  out.	  




Listeners	  were	  recruited	  from	  classes	  in	  Communication	  Sciences	  and	  
Disorders	  at	  James	  Madison	  University.	  	  Listeners	  volunteered	  their	  time	  and	  gave	  
informed	  consent.	  	  Inclusion	  criteria	  for	  the	  listener	  group	  included	  normal	  hearing	  
for	  age	  (able	  to	  pass	  audiological	  screening	  at	  30	  dB-­‐HL	  for	  500,	  1K,	  2K,	  3K,	  and	  4K	  
Hz),	  and	  native	  speaker	  of	  Standard	  American	  English.	  	  Exclusion	  criteria	  included	  
presence	  of	  disease,	  delay	  or	  disorder	  affecting	  listening	  or	  attending	  to	  task.	  
Speech	  Recording	  
Speech	  recordings	  were	  made	  in	  the	  home	  environment	  of	  each	  participant	  
and	  the	  pre-­‐session	  data	  is	  the	  same	  as	  was	  reported	  in	  Rountrey	  et	  al.,	  in	  
preparation.	  Both	  pre-­‐	  and	  post-­‐	  sessions	  were	  recorded	  using	  the	  LENA	  digital	  
language	  processor	  (DLP)	  (Ford	  et	  al.,	  2008)	  placed	  9	  inches	  from	  the	  mouth	  (Fig.	  2).	  	  
The	  DLP	  contains	  an	  omnidirectional	  microphone	  with	  a	  flat	  20-­‐20	  kHz	  frequency	  
response.	  	  Frequencies	  above	  10	  kHz	  are	  suppressed,	  as	  they	  are	  unlikely	  to	  contain	  
human	  speech	  activity.	  	  Low	  frequency	  sound	  is	  suppressed	  by	  a	  70	  Hz	  high-­‐pass	  
filter.	  	  Digital	  data	  were	  recorded	  using	  a	  10	  kHz	  low-­‐pass	  filter	  to	  suppress	  high-­‐
frequency	  sounds.	  	  Frequencies	  were	  recorded	  using	  a	  16	  kHz	  16-­‐bit	  sigma-­‐delta	  
analog	  to	  digital	  (ADC)	  converter	  with	  8x	  over-­‐sampling	  digital	  interpolation.	  	  
The	  LENA	  DLP	  has	  a	  hardware	  limiter	  for	  intensity	  suppression	  at	  87dbSPL.	  
This	  limiter	  was	  not	  problematic	  for	  this	  study,	  given	  that	  normal	  conversational	  
speech	  averaged	  81	  dB-­‐SPL	  at	  the	  microphone-­‐to-­‐mouth	  distance	  used	  of	  9	  inches.	  	  
No	  clipping	  was	  observed	  in	  the	  sentence	  samples	  that	  were	  gathered.	  	  When	  tested	  
on	  various	  frequencies,	  the	  DLP	  showed	  an	  equal	  flat	  response	  at	  125	  Hz,	  250	  Hz,	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500	  Hz,	  750	  Hz,	  1000	  Hz,	  1500	  Hz,	  2000	  Hz,	  3000	  Hz,	  4000	  Hz,	  6000	  Hz,	  and	  8000	  
Hz.	  
The	  DLP	  was	  calibrated	  using	  500Hz	  calibration	  tones	  at	  65,	  70,	  75,	  80	  and	  
85	  dB-­‐SPL.	  	  The	  tones	  were	  delivered	  via	  Grason-­‐Stadler	  GSI	  61	  clinical	  audiometer	  
and	  factory	  Grason-­‐Stadler	  speakers	  in	  a	  sound	  attenuated	  room.	  	  The	  DLP	  and	  a	  
sound	  level	  meter	  (set	  at	  50	  dB	  low,	  C-­‐weight,	  and	  fast	  speed)	  were	  both	  9	  inches	  
from	  the	  speaker.	  	  These	  calibration	  recordings	  on	  the	  DLP	  were	  saved	  for	  linear	  
interpolation	  to	  convert	  into	  dB-­‐SPL	  from	  Praat	  (Boersma	  &	  Weenink,	  2010).	  
The	  slopes	  and	  y-­‐intercepts	  derived	  from	  the	  linear	  interpolation	  for	  each	  of	  
the	  two	  DLPs	  used	  for	  the	  study	  were:	  (DLP	  1,	  slope=1.0447,	  y-­‐intercept=9.146,	  
R2=.9997;	  DLP	  2,	  slope=1.0447,	  y-­‐intercept=12.784,	  R2=.9997).	  
The	  DLP	  was	  clipped	  on	  participants’	  chests	  9	  inches	  below	  their	  mouth,	  to	  
record	  spontaneous	  speech	  and	  the	  assessment	  tasks.	  	  Recordings	  from	  the	  natural	  
environment	  were	  made	  in	  the	  participants’	  home	  and	  other	  non-­‐clinical	  settings	  in	  
which	  their	  primary	  conversational	  partner	  was	  usually	  their	  spouse,	  with	  informed	  
consent.	  	  Participants	  were	  instructed	  on	  maintaining	  a	  microphone-­‐to-­‐mouth	  
distance	  and	  given	  a	  ribbon	  to	  maintain	  the	  same	  mouth-­‐to-­‐microphone	  distance	  
over	  the	  two	  days	  of	  recording.	  	  They	  were	  also	  provided	  with	  written	  instructions	  
on	  making	  recordings	  with	  the	  DLP.	  	  None	  of	  the	  participants	  were	  wearing	  the	  
SpeechVive™	  during	  speech	  recordings,	  prior	  to	  the	  12	  weeks	  period	  or	  after	  device	  
use	  for	  12	  weeks.	  
Speech	  Tasks	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Experimental	  sessions	  began	  with	  reviewing	  consent,	  fitting	  of	  the	  LENA-­‐DLP,	  
and	  casual	  conversation.	  	  The	  Voice	  Handicap	  Index	  (VHI)	  (Jacobson	  et	  al.,	  1997;	  C.	  
A.	  Rosen	  et	  al.,	  2004)	  and	  Beck	  Depression	  Inventory	  (BDI)	  (Beck	  et	  al.,	  1996)	  were	  
collected.	  	  After	  approximately	  15	  minutes	  of	  conversation,	  participants	  were	  given	  
a	  hearing	  screening	  and	  the	  MMSE	  (Crum,	  Anthony,	  Bassett,	  &	  Folstein,	  1993;	  
Folstein	  et	  al.,	  1975).	  	  Instructions	  were	  given	  for	  formal	  speech	  testing,	  which	  
included	  the	  Sentence	  Intelligibility	  Test	  (Yorkston	  et	  al.,	  1996)	  and	  a	  script	  
recording	  of	  speech	  tasks,	  included	  for	  a	  previous	  study.	  	  
The	  participants	  were	  then	  instructed	  on	  the	  LENA-­‐DLP,	  recording	  
instructions,	  and	  confirming	  microphone-­‐to-­‐mouth	  distance	  of	  9	  inches.	  	  
Participants	  were	  given	  written	  instructions	  for	  device	  use	  and	  a	  letter	  to	  inform	  
any	  other	  conversational	  partners	  that	  they	  may	  encounter	  during	  the	  study	  about	  
the	  recording.	  	  They	  were	  instructed	  on	  how	  to	  switch	  the	  device	  on	  and	  off	  should	  
they	  or	  their	  conversational	  partner	  wish	  to	  have	  a	  private	  conversation.	  	  
Participants	  then	  completed	  15	  hours	  of	  recording	  within	  their	  home	  environments	  
over	  two	  days.	  	  They	  were	  instructed	  not	  to	  use	  the	  DLP	  in	  the	  presence	  of	  others	  
not	  made	  aware	  that	  the	  device	  was	  recording	  and	  agreeing	  to	  have	  their	  speech	  
recorded.	  
	   After	  recording	  in	  the	  home	  environment	  over	  two	  days,	  the	  participants	  
immediately	  enrolled	  in	  the	  SpeechVive™	  treatment	  study.	  	  During	  this	  time,	  they	  
wore	  the	  SpeechVive™	  device	  for	  3-­‐8	  hours	  each	  day	  for	  12	  weeks.	  	  The	  same	  
experimenter	  visited	  each	  participant	  every	  2	  weeks	  in	  their	  home	  to	  gather	  data	  for	  
the	  treatment	  study.	  	  At	  the	  end	  of	  the	  12-­‐week	  SpeechVive™	  study,	  the	  home	  study	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was	  repeated	  while	  wearing	  and	  not	  wearing	  the	  device.	  	  After	  completing	  the	  post-­‐	  
SpeechVive™	  recording,	  and	  returning	  the	  device	  to	  the	  examiner,	  each	  participant	  
received	  the	  LENA-­‐DLP	  and	  repeated	  the	  study	  within	  24	  hours	  or	  less	  of	  last	  
wearing	  the	  SpeechVive™	  device.	  	  A	  16-­‐hour	  sample	  was	  taken	  from	  the	  home	  
environment	  including	  spontaneous	  conversation	  with	  the	  primary	  communication	  
partner.	  
Data	  Processing	  and	  Analysis	  
Outcome	  Variable:	  Intelligibility	  	  	  	  
The	  same	  procedures	  as	  reported	  in	  Rountrey	  et	  al.,	  in	  preparation,	  were	  
used	  for	  this	  pilot	  study.	  	  Spontaneous	  utterances	  from	  the	  home	  environment	  were	  
reduced	  to	  conversational	  segments	  (periods	  without	  voice	  removed),	  time	  stamped,	  
and	  selected	  via	  a	  random	  number	  generator.	  	  Spontaneous	  utterances	  were	  
selected	  from	  the	  sound	  file	  by	  matching	  the	  random	  number	  generator	  to	  
timestamps	  on	  the	  recording.	  	  The	  nearest	  sentence	  within	  a	  conversation	  that	  met	  
the	  following	  criteria	  was	  selected:	  From	  intentional	  1-­‐on-­‐1,	  person-­‐to-­‐person	  
communication,	  between	  4	  and	  15	  words	  long	  without	  background	  noise	  interfering	  
with	  speech,	  and	  a	  unique	  sentence.	  	  Sentences	  were	  excluded	  if	  the	  conversation	  
was	  with	  more	  than	  one	  person,	  the	  conversational	  partner	  was	  not	  aware	  they	  
were	  being	  recorded,	  sentences	  were	  too	  long	  such	  that	  listeners’	  memory	  would	  be	  
taxed,	  or	  were	  repeated	  sentences.	  	  Ten	  randomly	  selected	  sentences	  from	  the	  home	  
environment	  were	  saved	  in	  a	  digital	  audio	  file	  (.wav)	  for	  intelligibility	  analysis.	  
Three	  different	  novel,	  inexperienced	  listeners	  transcribed	  each	  speaker’s	  
sentences,	  with	  no	  one	  listener	  hearing	  the	  same	  sentence	  more	  than	  once.	  	  Each	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volunteer	  listener	  passed	  a	  hearing	  screening,	  and	  was	  without	  delay,	  disorder,	  or	  
disease	  that	  would	  affect	  hearing	  and	  transcribing	  the	  sentences.	  	  Each	  was	  limited	  
to	  20	  minutes	  of	  listening	  to	  reduce	  listener	  fatigue.	  	  Listeners	  used	  laptops	  to	  
transcribe	  what	  they	  heard	  as	  the	  sentences	  were	  played	  for	  them.	  	  Amplification	  
levels	  on	  the	  speakers	  were	  set	  to	  match	  the	  same	  sound	  level	  meter	  values	  as	  were	  
read	  during	  the	  calibration	  tone	  session.	  Listeners	  were	  instructed	  that	  they	  would	  
hear	  each	  sentence	  only	  once	  and	  that	  they	  were	  to	  transcribe	  exactly	  what	  they	  
heard,	  without	  regard	  for	  punctuation	  or	  capitalization.	  	  They	  were	  told	  not	  to	  make	  
any	  corrections	  until	  the	  entire	  sentence	  was	  transcribed,	  to	  reduce	  their	  memory	  
load.	  	  Pauses	  were	  given	  until	  the	  listener	  was	  ready	  to	  start	  the	  next	  sentence	  and	  
after	  each	  set	  of	  10	  sentences.	  
Sentences	  were	  transcribed	  into	  Microsoft	  Excel	  spreadsheets	  and	  compared	  
with	  transcriptions	  made	  by	  the	  researchers,	  who	  listened	  to	  the	  sentences	  in	  
context	  for	  an	  unlimited	  number	  of	  times	  and,	  when	  needed,	  at	  a	  higher	  intensity.	  	  	  
Comparisons	  were	  made	  with	  R,	  Package	  ‘qualV’	  	  (van	  den	  Boogaart	  et	  al.,	  
2014)	  using	  the	  Least	  Common	  Sequence	  (LCS)	  function	  algorithm.	  	  Prior	  to	  running	  
the	  program,	  the	  entire	  spreadsheet	  was	  checked	  for	  spelling	  errors.	  	  The	  LCS	  
algorithm	  was	  adapted	  to	  do	  a	  number	  of	  things:	  text	  was	  converted	  to	  lowercase	  
without	  punctuation,	  single	  spaces	  between	  words	  and	  delete	  leading	  spaces,	  so	  as	  
not	  to	  count	  these	  as	  transcriber	  errors.	  	  The	  algorithm	  then	  created	  output	  columns	  
that	  look	  for	  the	  least	  common	  sequence,	  or	  the	  number	  of	  identical	  words	  that	  are	  
in	  the	  same	  sequence	  as	  the	  key	  sentence.	  	  Then,	  the	  number	  of	  identical	  words	  in	  
the	  sequence	  was	  divided	  by	  the	  greatest	  number	  of	  words	  in	  either	  sentence,	  so	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that	  errors	  of	  omission	  and	  commission	  are	  accounted	  for.	  	  This	  percentage	  was	  
used	  for	  “intelligibility.”	  
To	  determine	  the	  accuracy	  of	  the	  LCS	  algorithm,	  a	  random	  sample	  of	  10	  
sentences	  were	  calculated	  for	  intelligibility	  by	  hand,	  then	  compared	  to	  the	  LCS	  code	  
written	  for	  R,	  resulting	  in	  a	  perfect	  correlation	  (R2=1.0,	  0%	  error).	  The	  percent	  
intelligibility	  based	  on	  R	  was	  determined	  for	  each	  of	  the	  participants’	  in	  each	  
environment.	  	  
Outcome	  Variable:	  intensity	  
Intensity	  of	  the	  utterance	  was	  measured	  using	  Praat	  (Boersma	  &	  Weenink,	  
2010)	  software	  for	  speech	  analysis.	  	  Praat	  intensity	  was	  set	  to	  show	  a	  range	  of	  25dB	  
to	  100dB	  with	  “subtract	  mean	  pressure”	  checked	  as	  OFF.	  	  If	  pauses	  in	  the	  midst	  of	  
an	  utterance	  were	  greater	  than	  150	  ms,	  they	  were	  deleted	  (Hammen	  &	  Yorkston,	  
1996)	  before	  the	  mean	  intensity	  was	  computed,	  from	  the	  beginning	  to	  the	  end	  of	  the	  
sound	  contour.	  	  The	  intensity	  level	  was	  converted	  into	  decibels	  in	  sound	  pressure	  
level	  re	  .0002	  dynes/cm2	  using	  the	  slope	  and	  y-­‐intercept	  of	  the	  linear	  interpolation	  
derived	  from	  measurement	  of	  calibration	  tones.	  	  The	  mean	  of	  each	  participant’s	  
sentences	  in	  each	  environment	  was	  calculated	  and	  saved	  as	  “intensity”	  for	  statistical	  
analysis.	  
Statistical	  Methods	  
Repeated	  measures	  ANOVAs	  were	  used	  compare	  pre-­‐	  and	  post-­‐	  treatment	  
values	  of	  percent	  intelligibility	  and	  intensity	  in	  spontaneous	  speech.	  
Results	  
Participants	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Seven	  participants	  with	  idiopathic	  Parkinson’s	  disease	  (5	  men,	  2	  women,	  57-­‐
to	  74	  years,	  median	  70	  years)	  participated	  in	  this	  study	  (Table	  1).	  	  All	  participants	  
were	  on	  drug	  therapy	  and	  earned	  a	  minimum	  score	  of	  23/30	  on	  the	  MMSE	  (Folstein	  
et	  al.,	  1975).	  	  The	  range	  of	  overall	  impairment	  at	  the	  time	  of	  speech	  evaluation	  
extended	  from	  mild	  to	  moderately	  severe	  disability.	  	  Two	  participants	  had	  deep	  
brain	  stimulators	  and	  settings	  remained	  constant	  during	  the	  study.	  	  Of	  the	  7	  
participants,	  4	  reported	  no	  history	  of	  speech	  therapy,	  2	  reported	  Lee	  Silverman	  
Speech	  Therapy	  (LSVT),	  or	  “4	  weeks	  of	  talking	  loud,”	  and	  1	  reported	  another	  type	  of	  
speech	  therapy,	  the	  most	  recent	  speech	  therapy	  being	  1.5	  years	  prior	  to	  
participation	  in	  the	  study.	  	  There	  were	  a	  total	  of	  10	  volunteers	  who	  participated	  in	  
the	  pre-­‐SpeechVive™	  recording	  and	  volunteered	  for	  the	  SpeechVive™	  study.	  	  Two	  
did	  not	  complete	  12	  weeks	  with	  the	  SpeechVive™,	  and	  one	  opted	  out	  of	  the	  post-­‐
SpeechVive™	  recording.	  	  	  
Listeners	  
Fifty-­‐eight	  total	  listeners	  participated	  in	  the	  study,	  the	  same	  listeners	  who	  
participated	  in	  Rountrey	  et	  al.,	  in	  preparation.	  	  Their	  ages	  ranged	  from	  18	  to	  53	  
years	  (mean	  21.9	  years).	  	  None	  of	  the	  listeners	  had	  experience	  or	  completed	  
coursework	  in	  motor	  speech	  disorders	  or	  voice	  at	  the	  time	  of	  their	  participation.	  	  All	  
listeners	  were	  native	  speakers	  of	  Standard	  American	  English,	  free	  of	  neurological	  or	  
psychiatric	  disorders,	  and	  with	  visual	  acuity	  adequate	  to	  perform	  the	  task,	  and	  
passed	  a	  hearing	  screening.	  	  Sixty	  volunteered,	  one	  was	  excluded	  due	  to	  not	  passing	  
the	  hearing	  screening,	  and	  one	  was	  excluded	  after	  self-­‐reporting	  an	  auditory	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processing	  disorder.	  	  Most	  listeners	  did	  one	  session	  per	  day	  (n=53),	  and	  no	  more	  
than	  three	  sessions	  per	  day	  (n=3).	  
Repeated	  Measures	  ANOVA	  
SPSS	  version	  21	  was	  used	  for	  statistical	  analysis	  (SPSS,	  2012).	  	  Repeated	  
measures	  ANOVAs	  with	  a	  Greenhouse-­‐Geisser	  correction	  determined	  over	  time,	  
before	  and	  after	  application	  of	  SpeechVive™	  device	  for	  12	  weeks.	  There	  was	  no	  
significant	  difference	  in	  intelligibility	  F(1,6)=.176,	  p=.689,	  or	  intensity	  F(1,6)=.021,	  
p=.890.	  	  Therefore,	  it	  is	  concluded	  that,	  speech	  that	  is	  unaided	  does	  not	  show	  
changes	  following	  application	  of	  the	  SpeechVive™	  device	  for	  12	  weeks.	  
Power	  Analysis	  
	   A	  power	  analysis	  was	  conducted	  using	  G*Power	  version	  3.1.3	  	  (Faul,	  
Erdfelder,	  Lang,	  &	  Buchner,	  2007),	  using	  the	  data	  of	  these	  7	  participants.	  	  Percent	  
intelligibility	  change	  over	  the	  treatment	  period	  effect	  size	  was	  negligible,	  Cohen’s	  d	  
=	  .157.	  	  Change	  in	  intensity	  was	  also	  negligible,	  Cohen’s	  d	  =	  .055.	  	  The	  numbers	  of	  
participants	  needed	  were	  also	  computed	  for	  a	  power	  of	  .80.	  	  For	  detecting	  change	  
over	  the	  treatment	  period	  in	  percent	  intelligibility,	  314	  participants	  would	  be	  
required.	  	  For	  detecting	  change	  over	  the	  treatment	  period	  in	  intensity,	  2597	  
participants	  would	  be	  required.	  
Discussion	  
	   Application	  of	  the	  SpeechVive™	  device	  for	  12	  weeks	  did	  not	  elicit	  a	  difference	  
in	  unaided	  spontaneous	  speech	  intelligibility	  or	  intensity	  in	  the	  home,	  when	  
comparing	  pre-­‐treatment	  and	  post-­‐treatment	  within	  24	  hours	  of	  cessation	  of	  use	  of	  
the	  SpeechVive™.	  	  Further	  investigation	  with	  a	  larger	  sample	  size	  is	  not	  warranted	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given	  the	  small	  effect	  size	  when	  the	  patients	  were	  unaided.	  	  However,	  the	  sample	  
was	  comprised	  of	  only	  mild	  to	  moderately	  affected	  patients	  who	  may	  be	  less	  
susceptible	  to	  treatment	  effect,	  and	  repeating	  a	  similar	  experiment	  with	  a	  wide	  
range	  of	  impairment	  may	  yield	  different	  results.	  
In	  the	  present	  study,	  recordings	  were	  made	  anywhere	  the	  participant	  went	  
in	  the	  house,	  and	  participants	  were	  engaged	  in	  other	  activities	  besides	  pure	  speech	  
tasks.	  	  Differences	  in	  cognitive	  load	  and	  competition	  for	  cognitive	  resources	  have	  
been	  shown	  to	  have	  performance	  effects	  and	  distract	  attention	  from	  speech	  (Bunton	  
&	  Keintz,	  2006;	  Dromey	  &	  Benson,	  2003).	  	  	  
Given	  our	  findings	  of	  limited	  effects	  on	  unaided	  speech,	  the	  effect	  of	  the	  aid	  
may	  only	  be	  evident	  when	  the	  aid	  is	  being	  worn	  and	  turned	  on.	  	  However,	  six	  of	  the	  
participants	  in	  this	  study	  were	  judged	  to	  have	  mildly	  to	  moderately	  affected	  
speech/voice,	  while	  only	  one	  was	  moderate-­‐to-­‐severely	  affected.	  	  The	  patient	  with	  
the	  most	  severe	  impairment	  saw	  the	  greatest	  gain	  in	  intelligibility	  (difference	  pre-­‐
post-­‐=17.58%).	  	  This	  may	  indicate	  that	  the	  treatment	  might	  have	  a	  greater	  effect	  on	  
those	  with	  the	  more	  severe	  intelligibility	  problems.	  	  Expanding	  the	  number	  of	  
participants	  for	  this	  study	  with	  more	  severe	  speech	  impairments	  is	  recommended	  
for	  future	  study.	  	  However,	  the	  feasibility	  of	  a	  12-­‐13	  week	  study	  with	  320	  
participants	  or	  more	  should	  be	  considered.	  	  	  
Methods	  of	  investigating	  functional	  gains	  in	  home	  and	  natural	  environments	  
are	  in	  development,	  from	  dosimetry	  (Hillman,	  Heaton,	  Masaki,	  Zeitels,	  &	  Cheyne,	  
2006b)	  to	  use	  of	  accelerometers	  	  (Schloneger	  &	  Hunter,	  2015)	  to	  encrypted	  digital	  
recorders	  	  (Ford	  et	  al.,	  2008).	  	  In	  addition	  many	  remote	  sensing	  devices	  with	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analysis	  will	  become	  available	  with	  smartphones	  (Mehta	  et	  al.,	  2012).	  	  Exercises	  that	  
are	  carried	  on	  at	  home	  will	  need	  to	  be	  monitored	  for	  efficacy	  in	  the	  functional	  
environment	  of	  the	  patient,	  rather	  than	  in	  the	  clinic.	  
	   It	  is	  also	  important	  to	  note	  that	  recording	  large	  spontaneous	  speech	  samples	  
from	  the	  home	  environment	  is	  a	  unique	  and	  developing	  methodology	  in	  and	  of	  itself.	  	  
As	  technology	  advances,	  efficient	  and	  effective	  measurement	  of	  functional	  speech	  in	  
the	  home	  and	  other	  natural	  environments	  of	  those	  with	  voice	  and	  speech	  difficulties	  
should	  continue	  to	  progress.	  	  Practitioners	  are	  in	  need	  of	  normative	  values	  for	  
acoustics	  and	  intelligibility	  as	  measured	  in	  the	  home	  environment	  for	  healthy	  
controls	  as	  well	  as	  persons	  with	  PD	  and	  other	  disorders	  affecting	  communication.	  	  
Some	  of	  this	  information	  may	  be	  available	  in	  the	  data	  corpus	  from	  this	  study.	  	  
Continuing	  to	  analyze	  data	  from	  additional	  patients	  and	  healthy	  controls	  could	  yield	  
additional	  information	  on	  spontaneous	  speech	  in	  the	  home.	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Table	  1:	  Participants	  with	  Parkinson’s	  Disease	  Clinical	  Data	  (n=7)	  









Diagnosis	   MMSE	  
301	   72	   F	   50	   19	   10	   27	  
302	   74	   M	   40	   3	   10	   28	  
306	   70	   M	   37	   0	   13	   29	  
307	   63	   F	   52	   0	   10	   27	  
308	   65	   M	   60	   17	   15	   30	  
309	   57	   M	   8	   9	   2	   29	  
311	   73	   M	   18	   2	   2	   29	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Figure	  1:	  The	  SpeechVive™	  wearable	  device	  for	  treatment	  of	  hypophonia	  in	  
Parkinson’s	  Disease	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Figure	  2:	  LENA-­‐DLP.	  	  The	  DLP	  is	  2.5oz,	  measures	  approximately	  8cm	  x	  5cm	  x	  1cm.	  	  
Shown	  here	  compared	  to	  a	  U.S.	  quarter	  (2.4cm),	  and	  a	  schematic	  measuring	  the	  












	   This	  project	  set	  out	  to	  quantify	  the	  speech	  and	  voice	  behavior	  of	  persons	  
with	  Parkinson’s	  disease	  in	  their	  home	  environments,	  contrast	  that	  environment	  
with	  the	  clinical/laboratory	  environment,	  assess	  the	  predictability	  of	  home	  speech	  
behavior	  from	  clinical	  tasks,	  and	  measure	  changes	  in	  home	  speech	  behavior	  after	  
treatment.	  	  It	  was	  hypothesized	  that	  environment	  effects	  would	  be	  significant,	  that	  
significant	  clinical	  predictors	  would	  emerge,	  and	  that	  therapy	  would	  change	  speech	  
behavior	  over	  time.	  	  Many	  of	  the	  results	  of	  this	  inquiry	  were	  surprising.	  
	   It	  was	  concluded	  that	  when	  it	  comes	  to	  the	  “hallmark”	  sign	  of	  hypophonia	  
(reduced	  vocal	  loudness)	  in	  Parkinson’s	  disease,	  the	  participants	  with	  PD	  who	  
enrolled	  in	  this	  study	  did	  not	  differ	  from	  the	  healthy	  controls	  on	  speech	  intensity	  of	  
spontaneous	  sentences	  in	  either	  the	  home	  or	  clinical	  environments.	  	  Reduced	  
intelligibility	  was	  evident	  in	  our	  participants	  rather	  than	  reduced	  intensity,	  
regardless	  of	  environment.	  	  When	  we	  investigated	  common	  components	  of	  a	  clinical	  
evaluation,	  we	  found	  that	  vocal	  intensity	  on	  a	  sustained	  /a/	  was	  only	  useful	  as	  a	  
predictive	  measure	  of	  home	  intensity	  when	  it	  was	  combined	  with	  the	  Sentence	  
Intelligibility	  Test	  (SIT)	  	  (Yorkston	  et	  al.,	  1996),	  and	  that	  the	  SIT	  were	  significantly	  
predictive	  of	  home	  intelligibility	  on	  their	  own.	  	  When	  looking	  at	  treatment,	  we	  found	  
no	  significant	  gains	  in	  home	  spontaneous	  speech	  intensity	  or	  intelligibility	  after	  12	  
weeks	  of	  SpeechVive™ use,	  however	  our	  study	  was	  limited	  by	  a	  small,	  rather	  
homogenous	  sample	  group	  and	  only	  examined	  them	  when	  not	  wearing	  the	  device.	  
	   These	  studies	  together	  demonstrate	  a	  renewed	  importance	  of	  attending	  to	  
differences	  between	  environment	  and	  task	  when	  assessing	  functional	  speech,	  and	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that	  clinical	  measures	  are	  not	  necessarily	  accurate	  for	  predicting	  speech	  behavior	  at	  
home.	  	  New	  technologies	  are	  emerging	  such	  as	  those	  used	  for	  this	  study	  and	  others	  
that	  may	  have	  smartphone	  platforms	  and	  increased	  power	  and	  portability.	  	  
Ambulatory	  measures	  of	  speech	  and	  remote	  sensing	  of	  speech	  behavior	  and	  the	  
functional	  environment	  is	  a	  growing	  field	  with	  much	  investigation	  needed.	  	  
Standardized	  measures	  and	  efficient	  and	  effective	  methodologies	  are	  in	  
development	  for	  truly	  functional	  measures	  of	  speech	  behavior	  in	  the	  home	  for	  
baselines	  and	  measurement	  of	  home	  therapy	  activities	  and	  progress.	  
	  
